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Abstract  
Postoperative total knee arthroplasty (TKA) pain is severe and can inhibit patients’ 
rehabilitation. We devised a single injection motor sparing knee block (MSB) by targeting 
the adductor canal and lateral femoral cutaneous nerve with a posterior knee infiltration 
under ultrasound. Our primary objective was to evaluate the duration of the MSB compared 
to a standard periarticular infiltration (PAI) using time to first rescue analgesia as the end 
point. We randomized 82 patients undergoing TKA to receive either preoperative MSB or 
intraoperative periarticular infiltration.  Duration of analgesia was significantly longer in the 
MSB group with a mean difference of 8.8 hours. No significant differences were found in 
quadriceps strength, functional outcomes, side effects, satisfaction, or length of stay between 
groups. The MSB provided longer analgesia than the PAI while not negatively affecting 
quadriceps strength, length of stay, or functional rehabilitation.    
 
Keywords 
Total knee arthroplasty, motor sparing, nerve block, adductor canal block, periarticular 
infiltration 
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Chapter  1    
1   Introduction  
The total knee arthroplasty (TKA) is a highly successful procedure for treating patients with 
advanced osteoarthritis (OA)1. The number of knee replacement surgeries has risen over the 
past decade and is projected to increase 6-fold from 2005 to 2030 because of the aging 
population2. Severe acute postoperative pain may interfere with patients’ ability to sleep, 
walk, and participate in rehabilitation activites3.  
Traditionally, analgesia techniques such as patient-controlled analgesia (PCA), continuous 
epidural analgesia (CEA), lumbar plexus block (LPB), and femoral nerve blocks (FNB) 
have been performed to reduce pain during the immediate postoperative period. PCA using 
intravenous opioids and continuous epidurals pose the risk of side effects such as; nausea, 
pruritus, vomiting, dizziness, urinary retention, sedation, poor muscle control, and 
constipation4–7. LPBs require advanced skills and FNBs cause quadriceps weakness that 
increase the risk of inpatient falls8–10. 
It is important to preserve quadriceps strength in the immediate postoperative period, 
leading to early mobilization after surgery and enhancing functional recovery. Recently, 
adductor canal blocks (ACB) and periarticular infiltrations (PAI) have become popular 
because they are able to preserve quadriceps strength while providing similar postoperative 
analgesia to the traditional FNB3,11–15. One drawback to ACBs is that they do not provide 
analgesia to the posterior knee. Single injection PAIs performed at the end of surgery can 
have a shorter duration of analgesia15. Although continuous infusions prolong postoperative 
pain relief, the potential risk of joint infections caused by the catheter used to administer the 
infusion is an impediment to its popularity 5,16.  
We have developed a motor sparing knee block (MSB) for providing regional analgesia that 
minimally interferes with quadriceps innervation following TKA. Further, the MSB involves 
a combination of the single injection ACB with the addition of posterior knee infiltration 
and blockage of the lateral cutaneous nerve. Our clinical trial is the first to investigate 
whether there are any differences in duration of analgesia, quadriceps strength, function, 
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pain, satisfaction, side effects, and length of stay between the MSB and PAI techniques 
following TKA. We believe the MSB can serve as an attractive alternative regional block 
technique for patients undergoing TKA.  
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Chapter  2    
2   Literature  Review  
2.1   Anatomy  of  The  Knee  Joint  
2.1.1  Bony  Structures  
The knee is one of the largest and most complex joints in the body consisting of three 
bones; the femur, tibia, fibula, and patella17. The distal femur is asymmetrical allowing 
for attachment of various ligaments and tendons. The convex eminence of the medial 
epicondyle serves as the attachment point for the medial collateral ligament. The lateral 
epicondyle of the femur serves as the femoral attachment for the lateral collateral 
ligament. The epicondylar axis in normal knees is defined as the line that passes from the 
sulcus of the medial epicondyle to the prominence of the lateral epicondyle18. 
The tibia also consists of medial and lateral condyles and articulates with the distal 
femur. The prominent aspect of the tibia has a spine, which has an anterior depression 
that serves as attachments for the anterior horns of the medial and lateral menisci and 
anterior cruciate ligament (ACL)17. Anteriorly, the tibia has a tubercle that functions as 
the insertion point for the patella tendon. The Gerdy’s tubercle is located three 
centimeters laterally from this and is the insertion site for the iliotibial band (ITB)18. The 
fibula is a leg bone located laterally to the tibia. The head of the fibula forms the 
proximal tibiofibular joint with the lateral edge of the tibia. At its distal end, the fibula 
forms a lateral malleolus. At the medial malleolus of the tibia, the fibula forms the distal 
tibiofibular joint. Finally, the patella articulates with the trochlea of the distal femur17. 
The patella functions to protect the front of the knee and increase leverage through the 
range of knee extension19.  
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Figure 1: Structures of the knee joint 
Reprinted with permission from theodora.com/anatomy 
2.1.2   Muscles  
The anterior aspect of the upper leg consists of four muscles collectively called the 
quadriceps that function to extend the knee joint18. The rectus femoris muscle originates 
proximally from the ilium forming a muscle belly in the anterior thigh. It then narrows 
into a tendon above the patella.  The largest muscle of the quadriceps group, the vastus 
lateralis originates from the proximal intertrochanteric line of the femur extending 
halfway down the linea aspera17. The vastus lateralis ultimately inserts into the tibia. The 
vastus medialis, which is sometimes divided into the vastus medialis obliquus (VMO) 
and the vastus medialis longus (VML) originates from the intertrochanteric line and 
inserts with the other muscles of the quadriceps in the quadriceps tendon18. Lastly, the 
vastus intermedius originates at the lateral and anterior aspect of the femur. Its fibers also 
end in the quadriceps tendon.   Overall, the rectus femoris forms the most superficial 
layer of the quadriceps tendon. The vastus medialis and vastus lateralis contribute to the 
middle later, and the insertion of the intermedius forms the deepest layer17. After forming 
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the quadriceps tendon, these four insertions become the patellar tendon, which inserts at 
the tibial tubercle18. 
The sartorius, gracilis, semitendinosus, semimembranosus, and medial head of the 
gastrocnemius are all located at the medial side of the knee17. Collectively the 
semimembranosus, semitendinosus, and bicep femoris make up the posterior hamstring 
thigh muscles that function in knee flexion.  Known as the pes anserinus muscles, the  
sartorius, gracilis, and semimembranosus muscles flex and internally rotate the knee18. 
The lateral side of the knee contains the iliiotibial band (ITB), biceps femoris, popliteus, 
and lateral gastrocnemius muscles19.  
2.1.3   Menisci  
The menisci are two crescent-shaped fibro-cartilaginous structures functioning to deepen 
the tibial surface for the articulation of the distal femur19. Their circumferential pattern 
aids in absorbing the compressive load on the knee. Each meniscus covers approximately 
two-thirds of the matching articular surface of the tibia18. The medial meniscus is 
semicircular shaped and is broader posteriorly. The lateral meniscus is almost completely 
circular allowing it to cover a larger surface area. The menisci serve many functions such 
as aiding in load transmission by increasing the contact area, distribution of synovial 
fluid, enhancement of articular conformity, and prevention of soft tissue impingement 
during motion17.  
2.1.4   Ligaments  
The knee joint consists of four ligaments that provide stability to the knee. The anterior 
cruciate ligament (ACL) is the primary static stabilizer of the knee and prevents the tibia 
from shifting anteriorly to the femur. The ACL originates from the medial aspect of the 
femoral condyle at the posterior aspect of the intercondylar notch and travels in an 
anterior, distal, and medial direction toward the tibia18. The posterior cruciate ligament 
(PCL) functions to prevent the tibia from shifting posteriorly relative to the femur. It 
provides approximately 95% of the total restraint to posterior translation of the tibia on 
the femur17. The PCL originates posteriorly in the intercondylar notch of the medial 
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femoral condyle and attaches to the posterior intercondyloid fossa of the tibia18.The 
medial collateral ligament (MCL) is a broad flat membranous band originating from the 
medial epicondyle of the femur and runs to the medial condyle of the tibia. It functions to 
resist forces that would push the knee medially preventing valgus deformity. More 
narrow than the MCL, the lateral collateral ligament (LCL) originates from the lateral 
epicondyle of the femur above and travels to the head of the fibula below17. It also 
functions in maintaining knee stability as it moves through its full arc of motion19. 
2.1.5   Nerve  anatomy  of  the  lower  limb  
The nerves of the leg and foot arise from the lumbar and sacral roots arising from the 
spinal cord in the lower back and pelvis. These roots form two networks of crossed 
nerves called the lumbar plexus and sacral plexus18. The femoral, saphenous, obturator, 
and lateral femoral cutaneous nerves all extend from the lumbar plexus into the muscles 
and skin of the lower limb17. Innervation of the knee joint can be divided by location. The 
femoral nerve provides anterior and medial innervation to the knee18. Branches of the 
femoral nerve innervate the quadriceps muscles and skin of the anterior and medial thigh. 
Its largest branch the saphenous nerve, extends this innervation to the skin of the medial 
lower leg and foot17,20. The lateral femoral cutaneous nerve supplies the skin on the 
lateral region of the thigh.  
The saphenous nerve is the largest cutaneous branch of the femoral nerve and begins 
from the distal division of the femoral nerve8,11,17.  At the distal end of the adductor canal 
it penetrates the deep fascia on the medial area of the knee situated between the sartorius 
and gracilis tendons. The saphenous nerve divides into two branches; the infrapatellar 
branch of the saphenous nerve follows the sartorius muscle and innervates the 
anteromedial capsule, skin of the knee, and the patellar tendon18. The sartorial branch 
travels further distally and innervates the medial area of the lower leg and ankle11. 
The tibial nerve and obturator nerve function in posterior knee and medial thigh 
innervation respectively18. Branching from the long sciatic nerve originating from the 
sacral plexus, the tibial nerve begins in the distal posterior aspect of the thigh17. Running 
distally though the popliteal fossa, the tibial nerve continues between the two heads of the 
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gastrocnemius. The medial sural cutaneous nerve is a branch of the tibial nerve that 
travels on the surface of the gastrocnemius17. The largest articular branch of the tibial 
nerve, the posterior articular nerve arises within the popliteal fossa and then joins the 
popliteal plexus laterally.  
Finally, the common peroneal (or fibular nerve) enters the popliteal fossa lateral to the 
tibial nerve and continues distally along the medial side of the biceps femoris tendon. It 
branches into the lateral sural cutaneous nerve. It continues between the biceps femoris 
tendon and the lateral head of the gastrocnemius. Distally it travels superficially across 
the lateral aspect of the fibular neck before dividing into the superficial and deep peroneal 
nerves18. 
 
Figure 2: Nerves and Muscles of the Upper Leg 
Reprinted with permission from 
http://www.daviddarling.info/encyclopedia/F/femoral_nerve.html 
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2.1.6   Blood  Supply  
The adductor canal also known as the Hunter’s canal or sub-sartorial canal, is an 
aponeurotic tunnel in the medial aspect of the upper leg8,11,17,21. This canal extends from 
the beginning of the femoral triangle to the adductor haitus and contains the femoral 
artery, femoral vein, and branches of the femoral nerve. Coursing between the anterior 
and medial component of the thigh, the adductor canal is bounded anteriorly by the 
sartorius, postermedially by the adductor longus and magnus, and laterally by the vastus 
medialis muscle17,18.The femoral artery is the primary arterial supply to the lower limb. It 
descends from the femoral triangle and through the adductor canal.  Before passing 
through the adductor haitus the femoral artery becomes the descending genicular artery, 
which splits into two branches17.  The first branch is the saphenous branch, which 
accompanies the saphenous nerve to the medial side of the knee. The saphenous branch 
travels between the sartorius and the gracilis muscles before combining into the medial 
inferior genicular artery17,18. Secondly, the articular branch of the descending genicular 
artery passes through the vastus medialis and then forms an anastomosis with the medial 
superior genicular artery and anterior recurrent tibial artery17.  
The popliteal artery is a continuation of the femoral artery after it exits the adductor canal 
and before it enters the popliteal fossa18. It descends superficially to the popliteus fascia 
and then separates at the lower border of the popliteus into the anterior and posterior 
tibial arteries. Around the knee the popliteal artery divides into many muscular branches 
and specifically five genicular branches; the medial superior, lateral superior, middle, 
medial inferior, and lateral inferior17. All of these genicular branches supply blood to the 
peripheral third of the menisci, however a majority of the blood comes from the superior 
and inferior lateral geniculates18. Finally, the middle genicular artery forms branches that 
enter the synovium and form a plexus that covers the ACL and PCL.  These branches 
anastomose with vessels that run parallel to the collagen fibers.  
The anterior anastomosis of the knee joint connects the circulation of femoral artery with 
popliteal and anterior tibial arteries17. It is formed by the two medial genicular branches, 
the two lateral genicular branches, the descending genicular branch, the descending 
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branch of the lateral femoral circumflex, and the anterior recurrent tibial artery17,18. 
Collectively, these vessels surround the patella and then split into nutrient vessels at the 
inferior pole of the patella that ascend proximally on the anterior surface of the bone.  
The skin of the anterior knee receives blood from both the medial and lateral side, 
however the primary vascular supply comes from the medial side18. 
2.2  Osteoarthritis  
Arthritis is an umbrella term used to describe more than 100 diseases and conditions that 
affect the joints causing pain, swelling, and stiffness which often lead to disability19. It is 
one of the most prevalent chronic health conditions in Canada and is the second and third 
most common chronic conditions reported by women and men respectively22. As the 
most common form of arthritis, osteoarthritis (OA) also known as degenerative arthritis 
or degenerative joint disease, is caused by a group of mechanisms that result in the 
deterioration of joint cartilage and thickening of the bones underneath in one or more 
joints23,24. According to the World Health Organization (WHO), 9.6% of men and 18% of 
women older than 60 years of age worldwide have symptomatic OA, making this 
condition one of the most prevalent chronic conditions25. In Canada, one in ten adults are 
affected with OA26. As the disease progresses, joint damage, pain, and stiffness manifest 
with the knee being the most common joint involved27. Exact causes of OA can be 
difficult to determine however the condition has been divided into two types. Primary OA 
is when there is no identifiable initiating event, though risk factors may be present. 
Secondary arthritis occurs when there is a likely cause for the onset of OA. The most 
common cause of secondary OA is prior injury to the joint. However risk factors such as 
age, family history, excess weight, and overuse can contribute to OA development26. 
2.3  Non-­Operative  Treatment  
There are a number of conservative options to decrease pain and improve function for 
patients with mild and moderate OA. These options include: weight reduction, switching 
from high impact to low impact exercises (i.e. swimming, biking, elliptical trainer); using 
over the counter anti-inflammatory medications, physical therapy, and cortisone 
injections28. How long an individual should try conservative treatment is dependent upon 
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the recommendations from their physician. Once a patient’s OA becomes severe and 
conservative medical therapies are ineffective, surgery can be considered.   
2.4   Total  Knee  Arthroplasty  
The TKA has been established as a successful procedure for treating patients with 
advanced OA and functions to establish a functional less painful knee with improved 
longevity28,29,30. This procedure replaces the surfaces of the damaged knee joint bones 
through four basic steps19,28. First, the damaged cartilage surfaces and a small amount of 
underlying bone at the end of the femur and tibia are removed in order to prepare for the 
installation of components. These implants can be press-fit or cemented into the ends of 
the femur and tibia to recreate the surface of the knee joint22,28. The undersurface of the 
patella can be cut and resurfaced with an implant depending upon the patient and surgeon 
preference. Patellar resurfacing can be performed when patients have a loss of cartilage, 
exposed bone, gross surface irregularities, and or anterior knee pain. Finally, a plastic 
spacer is secured to the tibial component, with the goal of creating a smooth gliding 
femoro-tibial surface19. 
2.4.1  Epidemiology    
Total knee arthroplasty (TKA) is the most common elective orthopaedic procedure. It is 
performed for severe end-stage osteoarthritis and is associated with significant 
improvement in pain, function, and daily activities in patients29. This procedure is 
reserved for patients with intractable pain and functional limitations whom have failed 
conservative treatment and are not candidates for other procedures such as arthroscopy30.  
In 2004 Kurtz et al. developed a predictive model and concluded that because of an aging 
population, the number of knee replacement surgeries have drastically risen over the 
years and are projected to increase 6-fold from 2005 to 2030 in the United States2. 
Furthermore, according to the 2014 Annual Report by the Canadian Joint Replacement 
Registry (CJRR) between 2012-2013, approximately 57, 718 knee replacements were 
performed in Canada, which is a 21.5% increase from 2008-2009. More specifically there 
was a 5% increase in knee replacements from 2011 to 201331. As Ethgen et al. concluded, 
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patients with end-stage joint deterioration because of osteoarthritis or rheumatoid arthritis 
constitute the largest group of patients who require total knee replacements30.  
The demand for lower-limb arthroplasty is expected to increase, as indications for 
replacement surgeries extend as a consequence of advancements in prosthetic materials 
and expected clinical benefits. The etiology of knee pain that requires treatment with a 
TKA is often attributed to osteoarthritis, inflammatory arthritis, and post-traumatic 
arthritis28.  
2.4.2  Postoperative  Pain    
Since the TKA procedure is invasive, it is often associated with intense postoperative 
pain and therefore a comprehensive multimodal analgesic regimen4,11,32,33. Pain 
management after a TKA is of great importance because of the high incidence for severe 
acute postoperative pain which can interfere with patients’ ability to sleep, walk, and 
participate in rehabilitation activities required for hospital discharge3,34. Results from 
studies conducted by Chavis and Hawker et al. indicate a fear of poorly controlled pain or 
unrelieved pain during hospitalization may result in failure to achieve functional 
outcomes. In turn, this may contribute to increased risk for postoperative complications 
such as pneumonia, deep vein thrombosis, or pulmonary embolus35,36. Therefore adequate 
postoperative pain control is crucial in the immediate and early postoperative period 
when pain levels are typically the highest. Earlier discharge, which primarily involves 
early rehabilitation, is only possible if pain control is effective and muscle function is 
conserved37.  
2.5     Analgesic  Drugs    
Analgesics are any member of a drug class used to achieve a relief from pain. Since a 
substantial number of patients experience severe pain after TKA, healthcare professionals 
prescribe multiple drugs that work via different mechanisms to promote healing and 
recovery, faster patient mobilization, shortened hospital stays, and reduced healthcare 
costs 38. Major targets for analgesia following TKA are the opioid receptors, nociceptors, 
and local inflammatory mediators39.  
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2.5.1  Opioid  and  Nociceptors    
Immediately following surgical trauma, peripheral receptors are among the first 
expressed, subsequently relaying signals to central receptors40. When peripheral tissue is 
damaged, sensory neurons transduce noxious mechanical stimuli into action potentials. 
The cell bodies of these neurons are found in the dorsal root ganglia (DRG) and give rise 
to A-delta and C nerve fibers18. After synaptic transmission and modulation within the 
afferent neurons and spinal cord, nociceptive signals reach the brain where they are 
registered as pain. Opioids such as morphine and its derivatives; codeine, oxycodone, and 
hydrocodone can produce analgesia by activating opioid receptors on peripheral sensory 
neurons. Specifically morphine acts on three peripheral nerve opioid receptors (mu, delta, 
kappa) to exert an analgesic effect at the wound site18,40. As indicated by Stein and Lang, 
opioids are still the most powerful drugs for severe pain. However, their use is hampered 
by side effects such as respiratory depression, nausea, constipation, addiction and 
tolerance 40–43,44. As opioids bind to opioid receptors they cause a decrease in the 
excitability of the nociceptive neurons producing analgesia. Inhibition of nociceptors is 
increased by the use of local anesthetics such as ropivacaine15.  
2.5.1.1   Ropivacaine    
Ropivacaine is a local anesthetic drug belonging to the amino-amide group developed for 
the purpose of reducing potential toxicity and improving relative sensory and motor block 
performance 45. This drug is indicated for local anaesthesia often used in TKA operations 
such as local infiltration, peripheral nerve blocks, epidurals, and intrathecal anesthesia. 
Ropivacaine is related structurally to bupivacaine, with similar pharmacokinetic 
disposition but is less lipid soluble. Ropivacaine use has been popularized since 
bupivacaine was correlated with higher CNS and cardiac toxicity46.  
Ropivacaine’s mechanism of action is by reversible inhibition of sodium ion influx 
causing impulse blockage in nerve fibres. It has selective action on the pain-transmitting 
A delta and C fibres over the A beta fibres that are also involved in motor function45. This 
selective action is because of its less lipophilic nature than bupivacaine and its 
stereoselective properties. Ropivacaine has been shown to provide equal analgesia, allow 
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for greater mobility, and reduce opioid consumption in patients following TKA in 
comparison to opioid based analgesia47. Ropivacaine can also be administered as a 
cocktail containing epinephrine and Ketorolac47. Epinephrine functions to cause localized 
vasoconstriction to maintain optimal concentration of ropivacaine at the wound site48.  
2.5.2   Ketorolac    
Ketorolac is a non-steroidal anti-inflammatory drug (NSAID). It functions by inhibiting 
the production of prostaglandin inflammatory mediators by the eicosanoid pathway, 
exerting anti-inflammatory, antipyretic and analgesic effects39.  This serves to blunt the 
initial pain response. Andersen et al. found that local infiltration containing ketorolac in 
combination with ropivacaine and epinephrine resulted in patients consuming less 
postoperative morphine for pain in comparison to patients receiving no ketorolac in their 
analgesic cocktaila49.  
2.6     Analgesic  Techniques  
Adequate pain relief is extremely important in postoperative knee rehabilitation. Many 
modes of perioperative analgesia have been reported for patients undergoing TKA. 
Patient-controlled analgesia (PCA), continuous epidural analgesia (CEA), peripheral 
nerve blocks (PNB), and periarticular infiltration (PAI) are traditional and current pain 
management regimens. 
2.6.1   Patient-­Controlled  Analgesia  
Patient-controlled analgesia is a method that allows patients to administer their own pain 
relief through the use of a computerized intravenous infusion pump. Healthcare providers 
ensure the pump is programmed specifically for the patient’s pain relief and to prevent 
drug overdose. Traditionally, postoperative protocols for TKA were based on a general 
anesthetic and opioid intravenous PCA39. Although opioids provide effective analgesia, 
they are associated with side effects such as nausea, pruritus, vomiting, dizziness, urinary 
retention, sedation, and constipation4–6.  
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2.6.2   Continuous  Epidural  Analgesia  
Epidural analgesia involves the administration of drugs through a catheter placed in the 
epidural space. The epidural space is the outermost part of the spinal canal, specifically 
lying just outside the dura mater18. Within this epidural space, the spinal nerve roots and 
small arteries are found. Epidural analgesia involving the combination of a local 
anesthetic agent and an opioid has traditionally played a major role in orthopaedic 
anaesthesia since its analgesic efficacy is very high33. Studies have indicated that the 
benefit of epidural analgesia must be weighed against the risks of its adverse outcomes 
such as nausea, pruritus, hypotension, urinary retention, poor muscle control, and delayed 
mobilization7.  
2.6.3   Lumbar  Plexus  Blocks  
The inhibition of afferent pain fibers is the primary goal of peripheral nerve blocks. The 
optimal nerve block, combination of blocks and/or combination of catheter and single-
injection techniques is still a matter of debate33. Winnie et al. introduced an approach to 
blocking the lumbar plexus in the early 1970s8,50. The three nerves to the lower limb 
arising from the lumbar plexus: the obturator nerve, lateral femoral cutaneous nerve, and 
femoral nerve can be blocked by single injection. Also called the ‘3 in 1 block’, the 
placement of an indwelling catheter can allow continuous block of the lumbar plexus44. 
Winnie et al. indicated that the fascial envelope is identified by the production of a 
paresthesia of the femoral nerve. If a sufficient volume of anesthetic solution is injected 
to reach the lumbar plexus, a blockade of these nerves results50. Winnie described an 
anterior inguinal paravascular approach. In this technique a needle is inserted into the 
sheath that surrounds the femoral nerve. The injection is made just below the inguinal 
ligament, with the solution being forced cephalad to block the nerves at the level where 
they lie closer together in the lumbar plexus. A more common approach is the posterior 
lumbar paravertebral approach. The patient is placed on their side and a needle is inserted 
into the interfascial space between the quadratus lumborum and psoas major muscles. 
This allows the anesthesia to be placed where the roots form the plexus. The main risk of 
the advanced lumbar plexus block is the close proximity of the epidural space and retro 
peritoneum of the kidney.  Mislead catheters, kidney injuries, and local anesthetic 
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toxicity have been reported8,54. However, studies have shown that continuous lumbar 
plexus blocks (CLPB) have provided adequate analagesia for TKA patients51.  
A prospective cohort study conducted by Luber et al.52 enrolled 87 patients with similar 
characteristics (age, sex, height, and weight) to receive a combined lumbar plexus and 
sciatic nerve block. Their results indicated that 78% of their patients had successful pain 
relief using the block alone for an average of 13 hours post operation (range, 4.25-22) 52. 
Of the 87 patients, 86 completed a satisfaction survey that contained questions never used 
in literature previously. They found that the overall satisfaction rate was 92%, and 95% 
agreed to consider lumbar plexus blocks if future surgery was necessary. No control 
groups were used in this study. 
In 1991 Serpell et al.44 published a randomized clinic trial comparing the analgesic 
efficacy of CLPB to a control group for the first 48 hours following TKA. A total of 30 
patients were randomly assigned to receive the lumbar plexus block (n=13), or no block 
(n=16). The control group did not have a placebo injection at the femoral site. Both 
groups were attached to an on-demand analgesic computer (ODAC) set to deliver 
morphine upon return to the ward following surgery. The ODAC delivered morphine in 2 
mg intravenous boluses to a maximum of 12 mg/hour with a lockout interval of nine 
minutes. If further pain control was required, intramascular morphine 10 mg or 
paracetamol 1g orally was administered. Outcome measures included pain numerical 
rating scales (NRS), morphine consumption, and any adverse effects in the 48-hour 
postoperative period. Patients in the lumbar plexus group required a third less morphine 
than the control group in the total 40 hour postoperative period (mean(SEM), 60mg(8.7) 
vs 91mg(9.8) p<0.05). There were no significant differences in pain scores between the 
two groups at 24 and 48 hours and the incidence of nausea and vomiting was not 
significantly different between groups. Though this randomized control trial had a 
smaller sample size and functional outcomes were not assessed, Serpell et al. concluded 
that lumbar plexus blocks offer similar analgesia to continuous morphine, but with 
significantly reduced opioid requirements.  
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Watson et al.53 assessed functional outcomes in their randomized clinical trial comparing 
CLPBs to single injection lumbar plexus blocks (SLPB). They wanted to determine 
whether a block infusion is required or whether single-injection nerve blocks alone would 
be as a effective. A total of 32 patients were randomly allocated to the continuous block 
group (n=16), or the single block group (n=16). Both groups received PCA morphine, 
using a 1 mg bolus and a 5-minute lockout period with no background infusion. 
Outcomes measured were pain, morphine consumption, motor power, ambulation, and 
nausea. Results indicate that total morphine consumption over the 48-hour postoperative 
period was significantly reduced by 41% in the CLPB group compared to the SLPB 
group (19mg vs 32mg, p <0.05). Days to first mobilization after surgery were 
significantly reduced in the CLPB group: 5 patients in this group mobilized in the first 
operative day and the remaining 11 on the second day. In the SLPB group no patients 
mobilized on the first day, 10 on the second day, and the remaining 6 on the third day 
(p<0.01). No significant differences in pain, nausea, motor block, or time to meet 
discharge criteria were found between groups.  
. Kaloul et al.55 conducted a randomized trial comparing CLPB to continuous femoral 
nerve blocks (CFNB) in 60 patients undergoing primary TKA. Their aim was to evaluate 
the efficacy of CLPB and CFNBs for postoperative analgesia following TKA. Patients 
were randomly allocated to receive PCA with morphine (n=20), PCA plus CLPB (n=20), 
or PCA plus CFNB (n=20). Both continuous blocks were set to deliver an infusion of 
0.2% ropivacaine at 12 mL/hour for 48 hours following surgery. All patients received 
intravenous PCA with one milligram of morphine infused over two minutes with a five-
minute lockout period. Outcomes measured were morphine consumption, pain using a 
visual analogue scale, motor blockade (weakness in knee flexion against resistance), and 
satisfaction. CFNB and CLPB reduced morphine consumption during the 48-hour study 
period by 48% (p=0.0002) and 50% (p<0.0001) respectively compared to PCA. There 
was no statistical or clinical difference in morphine consumption between the CFNB and 
CLPB groups. Pain scores at rest were significantly reduced in the CLPB and CFNB 
groups compared to patients who received PCA (p<0.0001). Pain scores during 
physiotherapy did not differ between the three study groups. Patient satisfaction with the 
overall pain management was high with no significant differences between the groups 
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(PCA 86.5±10.3; CFNB 94.8±8.2; CLPB 93.0±7.8). However, motor blockade was 
achieved more frequently in the CLPB group than in the CFNB group (p<0.0001). Motor 
blockades can be linked to patient falls inhibiting adequate postoperative rehabilitation. 
Lumbar plexus blocks can be used as regional anesthesia for patients undergoing TKA; 
however because of the potential for complications and advanced skills to perform the 
block, it is currently not widely used8.  
2.6.4   Femoral  Nerve  Blocks    
The femoral nerve block (FNB) was first described in the 1920’s by Labat56.  In contrast 
to the lumbar plexus block, femoral blocks have a well-defined insertion site that is based 
on three land marks; the inguinal ligament, inguinal crease, and femoral artery8.  FNBs 
are common methods for postoperative pain control after TKA that are easy to administer 
and are associated with low risks of complications57. The femoral nerve alone only 
provides sensation to the anteromedial aspect of the knee. Therefore, the femoral nerve 
block can be performed in combination with a sciatic nerve block, which innervates the 
posterior aspect of the knee. Studies indicate that FNB’s offer improved or equivalent 
patient pain scores, length of stay, and morphine consumption compared to more 
traditional techniques57–59.   
In 2010, Paul et al.57 performed a meta-analysis of randomized trials that compared PCA 
opioids alone or epidural analgesia versus patients receiving FNB (single shot or 
continuous) for up to 72 hours following TKA. Studies included addressed at least opioid 
consumption and pain scores. Additional outcomes such as opioid side effects, knee 
range of motion, length of stay, early ambulation, and patient satisfaction were extracted 
if available. Following article screening, 23 RCT’s were extracted and assessed for 
quality. Of the selected studies included, 14 compared FNB with PCA, four compared 
FNB with epidural, three compared different types of FNB (single shot FNB, continuous 
FNB, sciatic combined with continuous or single shot FNB), and two compared FNB 
with both epidural and PCA. Overall 665 patients received FNB, 161 received epidural, 
and 190 received PCA. Regarding opioid consumption, patients receiving single shot 
FNB, sciatic combined with single shot FNB, and continuous FNB had significantly less 
morphine consumption at 24 hours (compared with PCA alone) with differences of -20, -
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31, and, -15 mg respectively. There were no significant differences in pain, motor block, 
patient satisfaction, and length of stay between comparison groups up to 48 hours 
following TKA. A small number of studies in this meta-analysis reported side effects; 
therefore all types of FNBs were grouped together in comparison with PCA. Results 
showed that FNB groups had significantly less nausea (0.31 odds) compared with PCA 
patients. 
Min Lee et al.59 conducted a retrospective study comparing PCA versus continuous FNB 
in 1582 post-TKA patients. Intravenous PCA was not used in patients who received FNB. 
Outcomes included the incidence of severe pain (visual analogue scale (VAS)>6), and 
incidence of adverse reactions.  One thousand and three patients received PCA and 579 
patients received FNB. The incidence of severe pain (VAS>6) from postoperative day 
(POD) 1-3 was higher in the PCA patients (69.1%) compared to the FNB group (32.3%) 
(p=0.003). There was one incident of hypotension and one incident of respiratory 
depression in the PCA group but no documented adverse events in the FNB group.  
Evidence published by Chan et al.60 in 2013 suggests that whether the FNB was 
performed as a single injection or a continuous FNB block, pain scores and functional 
outcomes were superior to PCA in the postoperative period. However, whether the FNB 
should be performed as a single shot block or as a continuous block was up for debate. In 
their randomized trial 200 TKA patients were allocated to one of three regimens; single 
FNB (n=69), continuous FNB (n=65), or intravenous PCA (n=66). All patients had 
similar characteristics. In the FNBs the local anesthetic used was 20 mL of 0.25% 
bupivacaine with 1:400,000 adrenaline (2.5 mcg/mL). For the continuous FNB the 
catheter was connected to a pump to deliver bupivacaine 0.125% 4 mL/h, which is the 
standard at this study’s center. PCA was initiated immediately after surgery via a pump 
set to deliver bolus doses of morphine 1mg with 5-minute lockout (maximum 10 mg/h). 
The primary outcome was significant pain on movement (VAS>4) at postoperative 24 
hours. Secondary outcomes were knee pain at rest or movement, cumulative opioid 
consumption, side effects, and days to achieve 90-degree active knee flexion. The 
proportion of patients with significant knee pain on movement at 24h after TKA was 
significantly lower in the single injection (OR 0.36; 95% CI 0.15 to 0.86; p= 0.022) and 
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continuous FNB groups (OR 0.25; 95% CI 0.11 to 0.60; p=0.002), compared to patients 
receiving PCA (OR 1). Knee pain at rest was significantly lower in the continuous FNB 
group at 6 hours (mean difference -1.19, 95% CI -2.18 to -0.21, p=0.018) and at 24h 
(mean difference -0.67, 95% CI -1.18 to -0.17, p=0.010) compared to the PCA group. 
Knee pain during movement was significantly lower in both the continuous (mean 
difference -1.15, 95% CI -1.72 to -0.58, p<0.0001) and single-injection (mean difference 
-0.58, 95% CI -1.14 to -0.01, p=0.045) FNB groups at 24h compared to the PCA group. 
The continuous FNB group reported significantly less pain on movement at 24h (mean 
difference -0.57; 95% CI -1.14 to -0.01; p=0.045), when compared to the single-injection 
FNB group. Prior to 24 hours there was no significant difference in pain between the 
single and continuous techniques. This result is most likely because of the duration of 
analgesia of the single-injection FNB block not lasting 24 hours. Opioid consumption for 
both FNB groups was significantly lower compared to the PCA group. The opioid 
consumption for the continuous FNB group was also significantly less compared to the 
single-injection FNB (mean difference at Day 1 morning: -18.5; 95% CI -25.6 to -11.4; 
p<0.001; and mean difference at Day 2 morning: -24.4; 95% CI -34.9 to -13.9; p<0.001).  
The single-injection (SI) and continuous (C) FNB groups reached ROM of 90 degrees 
earlier than the PCA group (SI: 2.3 days (1.4) p= 0.014, C: 2.4 days (1.4) p=0.024, PCA: 
3 days (1.6)). Recorded side effects were lower in the FNB groups compared to PCA. No 
adverse events such as falls were recorded. Length of stay was comparable regardless of 
allocation. Chan et al.60concluded that both single-injection and continuous FNBs were 
generally more effective than PCA, with continuous FNBs providing additional clinical 
benefits compared to single-injection FNBs. However, placement and management of 
catheters can be time consuming and require additional resources in terms of skill and 
cost which should be considered5. They recognized that their study was not designed to 
have sufficient statistical power to detect all small differences in treatment benefits 
between the two FNB groups. Furthermore, patients and clinicians were not blinded to 
treatment allocation and intraoperative parameters (spinal/general, PCA opioids) were not 
standardized since they followed their center’s protocols and clinician’s preferences.  
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One major reported drawback with FNBs is quadriceps weakness leading to inpatient 
falls in fast track arthroplasty regimens10,61.  A reduction in quadriceps strength of up to 
80% can be observed8,62. This occurs when efferent motor nerves are interrupted 
predisposing a patient to falls during the early postoperative period when rehabilitation 
practices are important1,63. Pelt et al., evaluated the rate of falls in 707 primary TKA’s 
performed at their center and found a 2.7% incidence rate64. They reported this incidence 
rate as unacceptably high. Ilfeld et al. also reported seven falls in 171 TKA patients 
receiving a femoral nerve block9. Each fall occurred in the experimental femoral nerve 
block group in this clinical trial. Catheter dislodgement and nerve injury can also occur 
during the patients’ recovery.  Memtsoudis et al. did not find an increase in the odds for 
inpatient falls when peripheral nerve blocks were used in a population based analysis of 
190,000 patients2. Therefore a careful choice of block technique and anesthetic volume is 
necessary after carefully weighing the benefits and possible limitations of each technique. 
2.6.5   Adductor  Canal  Blocks  
 The adductor canal block (ACB) or saphenous block is a modification of the FNB 
and has been gaining popularity in the anesthesia community over the last few years33. 
Initially described by Lund et al., the ACB block involves injection of local anesthetic 
into the adductor canal deep to the sartorius muscle resulting in an almost purely sensory 
blockade65. This block technique is a technically easy and reliable method for blocking 
the saphenous nerve66.  
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Figure 3: Cross-sectional MRI scan of the adductor canal.  
The scan shows the position of the saphenous nerve lateral to the artery and anterior to the vein. 
Arrow points to the saphenous nerve. A, femoral artery; V, femoral vein; LA, local analgesic; 
SM, sartorius muscle; RFM, rectus femoris muscle; VMM, vastus medialis muscle; ALM, 
adductor longus muscle; AMM, adductor magnus muscle; GM, gracilis muscle. 
Reproduced with permission from Lund et al. Continuous adductor-canal-blockade for adjuvant 
post-operative analgesia after major knee surgery: Preliminary results. Acta Anaesthesiol Scand. 
2011;55(3):14-1959.  
2.6.5.1  Adductor  Canal  Block  vs  Placebo  
Jenstrup et al.62 conducted the first blinded randomized clinical trial comparing the 
analgesic efficacy of a continuous adductor canal block to a placebo. Overall 75 patients 
were randomly allocated to receive an ACB with 0.75% ropivacaine (n=37) or a placebo 
infusion with isotonic saline (n=38). A continuous infusion of ropivacaine or saline was 
administered postoperatively as per allocation. All patients received intravenous PCA. 
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Postoperative outcomes assessed were cumulative morphine consumption, VAS pain 
scores, knee ambulation assessed by timed up and go (TUG) test, and nausea. Total 
morphine consumption from 0 to 24 hours postoperatively was significantly reduced in 
the ropivacaine group compared with the saline group (40±21mg vs 56±26mg; 
respectively, 95% CI -27 to -5mg; p=0.006). Pain scores during activity from 2 to 24 
hours was significantly lower in ropivacaine group (p=0.01).  This same result did not 
reach significance at rest. They concluded that administration of high-volume local 
anesthetic into the adductor canal is a useful option for postoperative analgesia after 
TKA. Patients in the ropivacaine group performed the TUG test at 24 hours 
postoperatively faster than patients in the placebo group (36 ±17s vs 50 ±29s, 
respectively p=0.03). There was no significant difference in this functional test at 26 
hours between groups. Regarding side effects, no significant differences in nausea or 
vomiting were found.  
By targeting the adductor canal, the largest sensory branch of the femoral nerve; the 
saphenous nerve, the medial femoral cutaneous nerve, and the articular branches of the 
obturator nerve are blocked. The nerve to the vastus medialis, a motor nerve is also 
blocked11.  As a result, the ACB leaves three out of the four components of the 
quadriceps muscle unblocked. Numerous studies have shown less reduction of quadriceps 
muscle strength, less reported falls, and improved functional outcomes in comparison to 
patients receiving the FNB11–14,62. 
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Figure 4: Ultrasonography image of the adductor canal.  
Midthigh level at a distance approximately halfway between the iliac spine and the patella. SM, 
sartorius muscle; A, femoral artery; V, femoral vein and branch. Arrow points to the saphenous 
nerve. 
Reproduced with permission from Lund et al. Continuous adductor-canal-blockade for adjuvant 
post-operative analgesia after major knee surgery: Preliminary results. Acta Anaesthesiol Scand. 
2011;55(3):14-1959.  
2.6.5.2   Adductor  Canal  Block  vs  Femoral  Nerve  Block  
In 2015, Grevstad et al.11 performed a randomized clinical trial hypothesizing that pain 
relief provided by the single injection ACB could improve functional quadriceps muscle 
strength in comparison to single injection FNB after TKA. In this single-center, 
randomized and blinded trial, 50 patients were randomized to receive either; 3x10 mL 
containers with 0.2% ropivacaine for the ACB and 3x10 mL containers with isotonic 
saline for the FNB (ACB group) or 3x10 mL containers with isotonic saline for the ACB 
and 3x10 mL containers with 0.2% ropivacaine for the FNB (FNB group). Patients with 
severe pain (VAS >60/100) were approached and assessed for study inclusion on post 
24 
 
surgical day one or two. All patients received a standardized multimodal analgesic 
regimen including local infiltration and slow-release opioids. The primary outcome was 
the difference of maximum voluntary isometric contraction (MVIC) of the quadriceps 
femoris muscle between groups at two hours after block performance. This result was 
expressed as a percentage of the baseline MVIC taken before block performance. TUG 
tests, ability to ambulate, pain scores at rest, activity, and during TUG test were assessed 
as secondary outcomes at two hours after block performance. Muscle strength was 
assessed with a handheld dynamometer. During the performance of TUG tests, all 
patients used a 4-wheel walker. Quadriceps MVIC was significantly higher in the ACB 
group, with a median change from baseline of 193% (95% CI, 143%-288%) vs 16% 
(95% CI, 3-33%) in the FNB group. At two hours after block performance all patients in 
the ACB group were able to perform the TUG test in comparison to 28%, (7/25) of the 
FNB group patients who could not. Of this seven, six were could not stand up because of 
muscle weakness and one because of dizziness. Patients in the ACB group performed the 
TUG test significantly faster (32 seconds, 95% CI 27-37s) compared to the FNB group 
(52 seconds, 95% CI, 41-62s), with a mean difference of 20 seconds (95% CI, 9-30s, 
p=0.001). No significant differences for pain at activity or rest were found between the 
groups from zero to two hours. Though this study demonstrated that ACB increased 
quadriceps muscle strength and functional outcomes compared to FNB, this study only 
looked at the immediate effects after block performance (2 hours) and did not investigate 
longer term (24-48 hours) functional or pain outcomes, which may be more clinically 
relevant. 
Patterson et al.12 conducted a retrospective chart review of TKA procedures performed at 
their center in order to determine if single injection ACB provided adequate analgesia 
and improved physical therapy performance in comparison in patients who received 
FNB. Patients in the ACB group (n=39) received single shot ACB with 15 to 30 cc of 
0.5% bupivacaine. Patients in the FNB group (n=41) received a catheter bolused with 30 
to 40 cc of 0.25% ropivacaine followed by a continuous postoperative infusion of 0.2% 
ropivacaine at 6 to 8 cc/h. In addition to the block, all patients received hydromorphone 
PCA as well as multimodal analgesia. Cumulative opioid consumption and pain scores 
(VAS) were assessed at discharge from the postanesthesia care unit (PACU), 8 ± 3, 16 ± 
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3, and 24 ± 3 hours. Functional outcomes measured were gait distance during 
physiotherapy at postoperative day one. Results indicated that there were no significant 
differences between groups in opioid consumption or pain scores at any of the time points 
assessed. However, the median gait distance was significantly greater in the ACB group 
compared to the FNB group (median, 25ft (4-60) vs. 6ft (4-60); p=.0009). Therefore, 
Patterson et al. concluded that single-shot ACB provides equivalent analgesia to a 
continuous FNB within the first 24 hours after TKA and improves gait distance during 
physiotherapy. Since every participant in this study received local infiltration it is not 
clear if the analgesic benefits were a result of the ACB or the local infiltration. 
Furthermore, all patients received postoperative hydromorphone analgesia, which could 
have further lowered pain scores. Adverse events and side effects were not reported and 
since data was collected retrospectively and without randomization, the study could have 
been biased. 
Kim et al. 13 conducted a blinded randomized trial comparing ACB to FNB in patients 
undergoing TKA. They hypothesized that ACB would cause less quadriceps motor 
weakness than FNB and provide non-inferior analgesia determined by pain scores and 
opioid use. Overall 94 patients were randomly allocated to receive FNB (n=47) or ACB 
(n=47). Patients in the ACB group received ultrasound-guided single injection ACB with 
15 cc of 0.5% of bupivacaine with 5 ug/mL epinephrine. Study patients in the FNB group 
received ultrasound-guided single injection FNB with 30 cc of 0.25% of bupivacaine 
with 5 ug/mL epinephrine. All patients received a standardized epidural PCA regimen, 
which was discontinued on postoperative day two. The primary outcomes measured were 
quadriceps muscle strength (via dynamometer) and pain scores (NRS) at baseline, six to 
8, 24, and 48 hours postanesthesia. Opioid consumption was measured from surgery to 
postoperative day two. Secondary outcomes included side effects, length of stay, and 
patient satisfaction. A joint hypothesis test was performed on all three primary outcomes 
previously mentioned at 6 and 8 hours postanesthesia administration. Results indicated 
that ACB was found to be non-inferior to FNB in motor score readings (mean difference 
5.2kgf; 95% confidence limit (3.1, 7.2); delta -3, p<0.0001). For pain scores at rest and 
opioid consumption non-inferiority was also found. Next, a superiority test was 
conducted and found only the muscle strength readings for the ACB to be superior to the 
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FNB readings (difference ACB-FNB kgf (98.3% CI), 5.2 (2.7-7.7); p<0.0001). Muscle 
strength readings were further compared and interestingly at 24 and 48 hours, the ACB 
and FNB groups were not statistically different (p<0.9999). For pain and opioid 
consumption at 24 and 48 hours, the ACB group was found to be no worse than the FNB 
group. No significant differences were found in secondary outcomes such as nausea, 
length of stay, and patient satisfaction. However, this study was underpowered to detect 
differences in nausea. In this study muscle strength was found to be reduced compared to 
baseline. They found that this could be because of nerve blockage to the vastus medialis, 
pain limiting painful extension, and the effects of surgery and tourniquet use on 
quadriceps strength. Successful pain relief in this study could have also been attributed to 
the postoperative use of an epidural PCA.  
Though numerous studies suggest that ACBs spare motor function to a higher degree 
than FNBs, practitioners still question the analgesic equivalence of these two approaches. 
The issue in this comparison is that pain perception is highly dependent on the individual 
causing inter-patient variability67.  
Memtsoudis et al.1 conducted a novel clinical trial to address this issue by randomizing 
60 patients undergoing bilateral TKA to receive ultrasound-guided FNB on one leg and 
ACB on the other. The primary outcome assessed was postoperative pain in either 
extremity at six to eight, 24, and 48 hours postoperatively. Secondary outcomes included 
motor strength and patient satisfaction. Patients, surgeons, physical therapists, and the 
research assistant performing follow-ups were blinded to the allocations. ACBs were 
performed by injecting 15 mL of 0.25% bupivacaine and FNBs with 30 mL of 0.25% 
bupivacaine. All patients received an epidural catheter to assist in postoperative pain 
control. Group one (n=30) had a left leg saphenous block and a right leg femoral block. 
Group two (n=29) had a right leg saphenous block and a left leg femoral block. Average 
pain levels at rest and with exercise were lowest at six to eight hours postoperatively and 
increased thereafter (p<0.001), but no significant differences were seen between 
extremities at any time point (p=0.4154). In a direct extremity comparison, 25.4% (15/60) 
of patients reported that the leg which received FNB was more painful, 50.9% (30/60) 
expressed that the side receiving the ACB had more pain and 23.7% (14/40) reported 
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both being equally as painful (p=0.0168). No significant differences in muscle strength 
were found between extremities at any time point or as an average in the postoperative 
period (p=0.7548). Patient satisfaction was also similar for both nerve blocks. Since all 
patients received epidural analgesia this can interfere with the independent impact of the 
nerve block outcome but each block should have been equally affected. Furthermore, 
bilateral TKAs could also be associated with more profound physiological changes and 
should be interpreted differently that unilateral TKAs1. They concluded that the use of 
ACBs vs. FNBs in knee arthroplasty patients yielded clinically similar results in pain 
scores, motor strength, and patient satisfaction.  
2.6.5.3   Continuous  Adductor  Canal  Block  vs.  Continuous  Femoral  
Nerve  Block  
A randomized trial conducted by Shah et al.14 assessed 98 patients comparing continuous 
ACB (n=48) to continuous FNB (n=50) after total knee arthroplasty. They aimed to 
investigate the efficacy of these two approaches with respect to: ambulation ability, pain 
control, opioid consumption, treatment related side effects, and length of stay. In both 
groups, the patients were given an initial dose of 30 mL of 0.75% ropivacaine, followed 
by repeated boluses of 0.25% ropivacaine every four hours until the second day after 
surgery. Patients also received intravenous PCA. Patients were assessed for pain at four, 
eight, 12, and 24 hours postoperatively using a VAS scale with 0= no pain and 100= 
worst imaginable pain. TUG tests and ten meter walk tests were performed at 24 hours 
post block performance to assess ambulation ability. Tug test results showed significantly 
better results in the ACB group as compared to the FNB group (95% CI -147 to -108.5; 
p<0.001). In the 10-m walk test assessments, the ACB group again performed 
significantly better than the FNB group (95% CI -236.33 to -177.06; p<0.0001).  Patients 
in the ACB had a significantly shorter length of stay then the FNB group (3.08 vs 3.92; p 
value <0.001).  Postoperative pain scores were lower in the ACB group than in the CFNB 
group at 4, 8, 12, and 24 hours postoperatively but without any significant intergroup 
differences (p value > 0.001). Finally, one patient in each of both groups had nausea and 
a single episode vomiting. In the study population, 71 out of 98 were females and both 
groups received intravenous PCA combined with oral analgesics which could influence 
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pain perception14. Blocks were also administered to patients immediate postoperatively. 
Shah et al. concluded that though continuous ACBs showed no significant difference 
from continuous FNBs in analgesic effect, ACB provided better ambulation ability and 
faster recovery post TKA. 
Overall, in the early postoperative period (24 hours post-op) ACBs seem to offer an 
improved retention in muscle quadriceps muscle strength in comparison to FNBs leading 
to an improved performance in rehabilitation activities.  Though ACBs have this 
advantage, studies indicate FNBs and ACBs are equivalent in outcomes such as pain, 
opioid consumption, and nausea in the early postoperative period11–14,20,62. Therefore 
ACBs can be a reasonable alternative and provide adequate analgesia and significant 
spared motor strength in comparison with the FNB.   
2.6.6   Periarticular  Injections    
Periarticular injections (PAI) or local infiltration is an analgesic technique which involves 
the injection of analgesic drugs into injured tissue such as the synovium, joint capsule, 
and subcutaneous tissues during TKA68,69.  It was designed to specifically avoid sedation, 
facilitate rapid physiological recovery, and to enable early mobilization and discharge by 
not compromising muscle tone5,70,71. These injections often use medications to target 
opioid receptors, nociceptors, and local inflammatory mediators39. First described by 
Kerr and Kohan, local infiltrations contain a mixture of ropivacaine (2mg/mL), ketorolac 
(30mg), and adrenaline (10ug/mL) in volumes of 150-170mL for TKA5,71.  Injections are 
usually administered in three stages during a TKA. The first injection is done after bone 
surfaces have been prepared before components are inserted to ensure access to the 
posterior joint capsule. Approximately 30-35 mL, is injected to the tissues around the 
posterior joint capsule, using a systematic sequence from one side to the other to ensure 
uniform delivery71. The second injection (35-50 mL) is done after component insertion 
but before wound closure and tourniquet release. This injection is into the deep tissues 
around the medial and lateral collateral ligaments and wound edges. The third injection 
(25-50 mL) is made into the subcutaneous tissue, carefully avoiding subdermal injection. 
Multiple injections are made in a systematic sequence. Each time the needle is inserted 
perpendicular to the wound edge to a depth of about 25mm, an injection is done as the 
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needle is withdrawn71. An intra-articular catheter for continuous infusions may be 
inserted preferably near the posterior aspect of the joint. Lastly, a compression bandage is 
applied to reduce degradation and slow the diffusion of local anaesthetic into the 
bloodstream42,72. 
A meta-analysis conducted by Xu et al. (2014)69 assessed the effectiveness and safety of 
single injection PIA in comparison to patients who received a placebo or no intervention 
after TKA. Studies included were RCTs that reported one or more of the following 
outcome measures: VAS, postoperative morphine consumption, length of stay, early 
functional recovery, and side effects. Following study screening and selection, 18 RCTs 
were extracted and included in their meta-analysis. Heterogeneity across studies was 
tested using the I2 statistic. If a moderate to high degree of heterogeneity existed, they 
estimated the influence of each individual study on the summary result. This post-hoc  
test consisted of repeating the random-effects meta-analysis after omitting each study one 
at a time. A total of 1858 study patients were involved in this analysis. Of the 18 studies 
analyzed, 16 reported VAS pain values in study patients. Analysis of these 16 RCTs 
indicated that patients receiving single injection PAI had significantly lower pain values 
at two, four, six, 12, 24, and 48 hours postoperative compared to control patients 
receiving saline injections or nothing (p<0.05).There was some heterogeneity amongst 
these sixteen studies and so they omitted one study at a time and calculated the pooled 
weight mean differences for the remaining studies. This post hoc analysis showed no 
changes in the direction of effect for pain when any one study was excluded. 
Only eight RCTs from the extracted studies reported postoperative morphine 
consumption. Analysis of these eight RCTs indicated that single-dose PAI was associated 
with decreased postoperative morphine consumption (WMD -5.21, 95% CI -9.89 to -
0.52; p =0.03; heterogeneity p<0.01, I2= 79.1%).They decided to repeat the random-
effects meta-analysis after omitting one out of the eight studies at a time since there was 
significant heterogeneity. When one study was excluded during this post-hoc exploration, 
the direction of effect changed indicating no significant difference between groups in 
postoperative morphine consumption. This was a separate result and the authors did not 
indicate which was correct. The time to short leg raise (4 studies) was significantly 
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shorter in the PAI group than the control groups (WMD, -2.75 days; 95% CI, -3.61 to -
1.90; p <0.01; heterogeneity p<0.01, I2 = 85.4%). After the same post-hoc single 
exclusion of studies because of heterogeniety, there were no changes in these results. No 
significant differences were found between PAI and control groups regarding 
postoperative nausea and vomiting, pruritus, and DVT. This meta-analysis demonstrated 
considerable heterogeneity across the trials, which could have resulted from non-
standardized PAI (medication ingredients, dosages). A major limitation in this meta-
analysis was the post-hoc exclusion of studies to explore if there was a change in the 
direction of effect. If one study was excluded and the direction of effect changed they 
would not report which was the correct result. Furthermore, different patients might have 
had varying responses to analgesia because of the type of anesthetic used during surgery 
and postoperative multimodal regimens. Overall, this study concluded that that single 
injection PAI is significantly better than placebos at relieving pain, and might accelerate 
early functional recovery of the knee while not increasing the prevalence of side effects 
during postoperative observations.   
2.6.6.1   Periarticular  Infiltration  vs.  Placebo  or  Traditional  Analgesia  
Compared to more traditional analgesic methods (PCA, intrathecal narcotics, or 
epidurals) in placebo controlled studies, patients receiving single injection or continuous 
PAI had equivalent or lower pain scores in the postoperative period39,47,73,74, lower 
consumption of morphine4,39,47,73,74, better functional outcomes39,47,75, and less 
complications4,43,47. Evidence has lead to peripheral nerve blocks and PAI largely 
replacing epidural analgesia for postoperative pain management following TKA76.  
In 2014, Niemelainen et al.73 randomized 56 patients undergoing TKA to receive either 
single injection PAI or placebo in this study. In the PAI group, a cocktail mixture of 
levobupivacaine (150 mg), ketorolac (30 mg), and adrenaline (0.5 mg) for a total volume 
of 150 mL was infiltrated. In the placebo group saline was infiltrated for a total volume 
of 150 mL. Only an independent nurse who prepared the study solutions was unblinded 
to group allocations. In addition, all patients were given PCA with oxycodone to ensure 
pain relief. The primary outcome assessed was oxycodone consumption over 48 hours 
postoperatively. Secondary outcomes included pain and range of motion (ROM). Overall 
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27 patients in the PAI group and 29 patients in the placebo group completed the study. 
Results showed that cumulative consumption of oxycodone was smaller in the PAI group 
to that in the placebo group at all measured time points up to 48 hours. However, in 
comparison of the different time intervals, the PAI group used significantly less 
oxycodone than the placebo group during the first six hours (mean: 14 (2-34)mg vs 30 (6-
57)mg ; p<0.001). The rest of the time points did not reach statistical significance. Both 
groups achieved a median level of pain (VAS <3) until 48 hours. The difference in mean 
ROM at 6 hours between the PAI group and the place group was -26 degrees (95% CI: -
39 to -12). Niemelainen et al. showed that a single intraoperative PAI containing 
levobupivacaine, ketorolac, and adrenaline reduced the total consumption of oxycodone 
during the first 48 hours postoperatively.  The beneficial effect of single injection PAI 
was most pronounced during the first six hours as seen by the increased ROM and equal 
pain scores were recorded between both groups. This study however did not measure 
length of stay between groups. Levobupivacaine was also used in the PAI cocktail, which 
according to Niemelainen et al. has a longer effect time than ropivacaine. In theory this 
should prolong postoperative analgesia. 
Lamplot et al.39 performed a randomized controlled trial of patients undergoing a primary 
TKA. Patients were either randomized to receive either intraoperative single injection 
PAI and inpatient multimodal analgesics (PAI group) or to hydromorphone PCA (PCA 
group). During surgery patients in the PAI group received single injection PAI consisting 
of 30 cc 0.5% bupivacaine, 10 mg MSO4, and 15mg ketorolac. Postoperative multimodal 
pain management was given to these patients. During surgery, patients in the PCA group 
received no injections. For postoperative pain management these patients received 
hydromorphone PCA. Recorded measures in this study consisted of; VAS pain scores, 
narcotic consumption, medication-related adverse effects, length of stay, satisfaction, and 
time to physical therapy milestones. Overall, 36 patients of an eligible 55 were 
randomized to the two groups; PAI (n=19) and PCA (n=17). Daily narcotic consumption 
was significantly lower in the PAI group compared to the PCA group, with 17.0mg±3.85 
versus 40.5±12.7 at the end of postoperative day 0, 30.8±5.5 versus 71.8±15.5 during day 
1 and 18.4±5.5 versus 38.1±11.5 during day 2, respectively (p<0.007). During the 
hospital stay, fewer patients in the PAI group (3/19) experienced narcotic-related adverse 
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effects in comparison to the PCA group (16/17), including nausea, vomiting, 
constipation, insomnia, pruritus, and mood irritability (p<0.01).  The VAS pain scores for 
postoperative pain at rest (p<0.0004) and activity (p<0.001) were significantly lower in 
the PAI group during each day of hospitalization. The ability to walk assisted >50ft was a 
physical therapy milestone recorded in this study. For this milestone 7/17 patients in the 
PAI group were able to perform this compared to 0/16 in the PCA group. Furthermore, 
on day one after surgery 19/19 patients in the PAI group were able to achieve this 
milestone compared to 6/17 in the PCA group. There was a trend toward decreased 
length of stay in the PAI group, with a mean of 1.9 days compared to 2.3 days in the PCA 
group. Patients in the PCA group also reported significantly higher satisfaction scores 
compared to the PCA group during each postoperative day (p<0.05). Lamplot et al. found 
the patients receiving intraoperative single injection PAI had significantly improved 
patient pain control, medication-related adverse effects, functional outcomes, and patient 
satisfaction. Though this study seemed to have a small sample size, it was unanimously 
decided at their center that patients in the PAI group were having markedly better 
outcomes. Therefore, they stopped short of reaching their goal of enrolling 30 subjects in 
each group.  
2.6.6.2   Single  vs.  Continuous  Periarticular  Injections  
In subsequent years, different cocktail mixtures of opioids and steroids have been 
administered to patients with no agreed upon gold standard mixture4,33. This discrepancy 
is because of considerable variability in factors affecting drug therapy outcomes in 
available clinical studies. PAIs can either be performed as single or intermittent 
injections, continuous infusions with the use of an intra-articular catheter, or a 
combination of methods, and with varying compositions of the drug solution77. 
Controversy exists over which model of delivery is most effective.  Continuous infusions 
often involve catheter placement by the surgeon at the end of surgery under aseptic 
conditions while requiring the use of bacterial filters and closed infusion systems. 
Catheters are difficult to manage with the potential for problems while troubleshooting 
them5. However, the placement of a catheter in continuous infusions allows for prolonged 
site-specific regional analgesia which may be beneficial16. By contrast, single injection 
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PAI is common in clinical practice and reported to be inexpensive and relatively easy to 
perform and have fewer side effects69.  
Zhang et al.16 conducted a randomized blinded and placebo-controlled trial with the aim 
of evaluating whether continuous PAI provided prolonged and superior analgesia and 
reduced morphine consumption in comparison to single PAI. A total of 80 study patients 
completed the study and were randomly allocated into three groups; continuous PAI 
(n=27), single injection PAI (n=27), or a control group (n=26). Patients in the continuous 
PAI group received ropivacaine (190mL, containing 2mg/mL) via continuous infusion 
(flow rate 4 mL/h for 48 hours) plus 2 mL ketorolac (30mg/mL) at 1.25 mg/h. Patients in 
the single injection PAI and control group received a continuous infusion of saline 
through the catheter. Study patients in the continuous and single PAI groups at the end of 
surgery received periarticular infiltration of a mixture of ropivacaine 150mL (2mg/mL), 
ketorolac 1mL (30mg/mL), and adrenaline 0.5mL (1mg/mL). For rescue analgesia, all 
patients received intravenous PCA consisting of morphine for the first 48 hours post 
surgery. Knee pain was evaluated after surgery at two, four, eight, 12, 16, 20, 24, 30, 36, 
and 48 hours and the amount of morphine delivered via the PCA pump was also 
recorded. Patient satisfaction and complications during the follow-up period of three 
months were recorded. The resulting VAS pain scores at rest and during activity were 
significantly higher in the control group than in the continuous PAI group (p<0.05) 
through the 48 hour postoperative period. In contrast, no significant differences in the 
VAS pain scores at rest between the control group and single injection PAI group at 20-
48 hours postoperatively were found. VAS pain scores in the continuous PAI group were 
significantly lower than the single injection PAI group (p<0.05) from eight to 48 hours 
postoperatively at rest and from 16 to 48 hours postoperatively during activity (p<0.05). 
Morphine consumption was only significantly higher in the control group compared to 
the single injection PAI group during 0-12 hours and 12-24 hours postoperatively 
(p<0.05). In comparison to the continuous PAI group morphine consumption was 
significantly higher in the control group throughout the entire 48-hour postoperative 
period (p<0.05). In addition, morphine consumption from 24-48 hours was significantly 
reduced in the continuous PAI group compared to the single injection group (p<0.05). 
The incidence of nausea and vomiting was higher in the control group than the two PAI 
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groups however this difference was not statistically significant. There were no significant 
differences in satisfaction between the two PAI groups, and no complications, infections, 
or reparations occurred during the follow-up period. This studies sample size was too 
small to evaluate the risks of infection in the different techniques. Zhang et al.16 
concluded that continuous PAI is associated with prolonged, superior analgesia and 
reduces morphine consumption compared to single injection PAI over the 48-hour 
postoperative period. They also recorded a higher incidence of patient satisfaction in the 
continuous PAI group but still state that it is important to consider the risk of infection 
with different PAI techniques.  
2.6.6.3   Periarticular  Infiltration  vs.  Femoral  Nerve  Blocks  
Recently, Wang et al.78 conducted a systematic review and meta-analysis comparing 
PAIs and FNBs for postoperative pain management in TKAs. Randomized control trials 
were identified that compared patients receiving PAI or FNB whether they were single or 
continuous techniques. Outcome assessed were; pain scores, opioid consumption, 
functional outcomes, length of stay, and side effects. Following study exclusions, ten 
RCTs were identified with a total of 744 TKAs performed in 728 patients. In this 
analysis, four studies used PAI with a catheter and six as a single injection. Six studies 
performed a continuous FNB while the other three used a single injection FNB. One 
study looked at bilateral TKAs. Results of nine RCTs that were analyzed indicated that 
there were no significant differences in VAS pain scores at rest between the PAI and 
FNB group at 24 hours postoperative (95% CI -0.62 to 0.37; p=0.62). A subgroup 
analysis was performed on the different analgesic techniques (single or continuous). A 
meta-analysis of two of their studies showed that single injection FNBs had lower VAS at 
rest pain scores at 12 hours than single injection PAI (95% CI 0.18 to 0.79, p=0.002).  
However, the results of four combined studies indicated single injection PAI significantly 
reduced VAS pain at rest at 24 hours compared to single injection FNBs (95% CI -1.44 to 
-0.09; p=0.03). No significant differences were found between the two groups regarding 
pain at activity. A total of seven studies in this meta-analysis were analyzed for total 
opioid consumption and no significant differences were found between PAI and FNB at 
24 hours (p=0.64) or at 48 hours (p=0.99) postoperatively. Three studies indicated that 
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the number of patients able to do active straight leg raises at 24 hours following TKA was 
significantly larger in the PAI group (OR=11.09; 95% CI=6.24 to 19.69; p<0.001). Meta-
analysis results from six studies of 390 TKAs showed that patients receiving PAI had 
significantly shorter length of hospital stay then FNB patients (95% CI -0.52 to -0.02; 
p=0.04). No significant differences were found in complications such as nausea, 
vomiting, and wound complications between the two groups. It appears that continuous 
PAIs are an efficient and safe alterative to continuous FNBs for postoperative pain 
management following a TKA. However, in this meta-analysis there was a lack of 
uniform technique of PAI and FNB. Furthermore, single injection FNBs may provide 
better pain relief in the early postoperative period compared to single injection PAIs.  
2.6.6.4   Single  Injection  Periarticular  Injections  vs.  Single  Injection  
Femoral  Nerve  Blocks  
In a large randomized blinded trial by Uesugi et al.15, 210 patients undergoing a TKA 
were randomized to receive either single injection PAI (PAI group) or a single injection 
FNB with a combined sciatic block (FNB group). Patients in the PAI group (n=100) 
received intraoperative periarticular injections containing 20mL of 0.75% ropivacaine 
and 0.3mg of adrenaline. Patients in the FNB group (n=100) received a total 30mL of 
0.75% ropivacaine for peripheral nerve blockade as per the standard of their center. If 
patients were in postoperative pain they were given diclofenac sodium suppositories 
(25mg) as required. Primary outcomes measured were postoperative pain, total rescue 
medication consumption, motor paralysis, satisfaction, and complications. Results 
indicated that from three to six hours following surgery pain scores were significantly 
lower in the FNB group (p<0.01, p<0.01). No significant differences were found between 
the groups from 12 to 18 hours postoperatively. Pain scores were significantly lower in 
the PAI group at 24 hours (p<0.01) and 30 hours (p<0.01). From 30 hours on there were 
no significant differences between the two patient groups. During the zero to 12 hour 
postoperative period, patients in the FNB group used significantly fewer rescue pain 
medications than patients in the PAI group (6h p<0.01, 12h p<0.01). However from 12-
24 hours after TKA, the PAI group used significantly fewer rescue pain medications than 
patients who received FNB (12h p=0.03, 18h p<0.01). When the total number of rescue 
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analgesia was analyzed throughout the entire 48-hour period after surgery there were no 
significant differences between groups. The duration of analgesia was shorter in patients 
who received PAI (p<0.01) but motor paralysis of the ankle was significantly longer in 
the FNB group (p<0.01). Investigators found no significant differences between the 
groups in complications and patient satisfaction. In this study, patients in the FNB group 
received their FNBs in combination with sciatic nerve block injections, which may 
explain why pain scores favoured the FNB group in the early postoperative period up to 
six hours. Furthermore, the number of functional measures reported in the early 
postoperative period was limited and since this is the timeframe where PAI is expected to 
be most effective, the study may have been unable to detect important differences. 
Uesugi et al.15 concluded that single injection PAI provided a similar analgesic effect to 
the combined use of sciatic and FNBs and since both techniques were administered as 
single injections, continuous managements was not required. Furthermore, motor 
paralysis in the PAI group was shorter which can lead to improved rehabilitation.  
In 2013, Ashraf et al.10 conducted a similar randomized trial comparing single injection 
PAI to single injection FNB. Overall 42 patients were randomized, 22 patients in the 
FNB group (30mL 0.2% ropivacaine) and 20 patients in the PAI group (150mL 0.2% 
ropivacaine/1 mL 1:1000 adrenaline/30 mg ketolorac). The primary outcome measure 
was postoperative pain assessed by VAS at four hours postoperatively. Secondary 
outcomes assessed were pain at two hours, pain at rest and after physiotherapy on 
postoperative day one (POD1), total opiate use, length of stay, and functional outcomes. 
All patients received PCA to assist in pain management. Results showed that at four 
hours postoperatively patients in the PIA group (2.1±2.6) had significantly lower pain 
scores than patients in the FNB group (6.8 ±3.2). This difference of 4.7 points was 
statistically significant (p<0.01, 95% CI 2.8 to 7.5). There were no significant differences 
in pain scores between the two groups at two hours post TKA. Pain at rest and after 
physiotherapy on POD1 showed no significant differences between the two study groups. 
However, patients in the PAI group consumed significantly less opiate analgesia during 
their stay at the hospital compared to patients in the FNB group (p=0.01). There were no 
significant differences between the two groups in functional outcomes and length of stay. 
This study demonstrated that single injection PAIs provide better pain relief in the early 
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postoperative period and overall lower use of opiate analgesia in comparison to single 
injection FNBs. However, this study had a small sample size, surgeons were unblinded, 
and less ropivacaine was used in the FNB group (30mL) as compared to the PAI 
group(150mL). Furthermore, this study was underpowered in their assessments of 
functional outcomes.  
PAIs can be seen as advantageous to FNBs since special skills are not required to 
administer the injection into the periarticular tissues. As Uesegi et al. described, the 
analgesic effect is simply achieved by injecting the solution around the joint while being 
careful to ensure that it does not enter a blood vessel15.  
2.6.6.5   Single  Injection  Periarticular  Injections  vs.  Continuous  
Femoral  Nerve  Blocks    
Various studies indicate that single injection PAIs offer equivalent analgesia to 
continuous FNBs in the 48 hour postoperative period and similar side effects, while 
providing better functional outcomes because of its absence of motor block41,79–81. In a 
randomized trial conducted by Chaumeron et al.3, 60 TKA patients were randomized to 
receive a single injection PAI (n=30) or continuous FNB (n=30). One patient in the PAI 
group was excluded prior to surgery because of the inability to receive a spinal. More 
patients in the FNB group experienced motor block, were unable to perform a straight leg 
raises, and one patient experienced a fall requiring corrective surgery3. During this study 
PCA was available for additional analgesia during the first 48 hours. In the PAI group, 
the infiltration mixture consisted of 30mg ketorolac, 0.5mL adrenaline (1/1000), and 275 
mg ropivacaine for a total mixture of 108mL and a simulated FNB to ensure blinding. 
Patients randomized to the FNB group received an injection of 20mL ropivacaine and a 
0.25% continuous infusion at 8-10mL/hour through a femoral catheter. The primary 
outcome was morphine consumption with PCA during the first 48 hours after surgery. 
Secondary measures assessed were daily pain scores (at rest and activity), length of stay, 
motor blockage, and functional outcomes. Significantly higher morphine consumption 
was observed from zero to eight hours after surgery in patients who received the FNB 
(p=0.04). However, there was no significant difference between the two groups in 
morphine consumption over the rest of the 48-hour postoperative period. No significant 
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differences in postoperative pain were found between the two groups, however more 
patients who received the continuous FNB group experienced motor block (11/30) 
compared to patients in the PAI group (0/30) (p<0.001). On POD1, more patients in the 
FNB group (6/27) compared to zero in the PAI group were unable to stand (p=0.018).  
The proportion of patients unable to perform a straight leg raise on postoperative days 
one to three was greater in the FNB group (p<0.001-0.002). Furthermore, patients in the 
PAI group walked longer distances on POD zero, two, and three (p=0.004-0.031). A 
similar number of complications were reported in each group. This study concluded that a 
single injection PAI showed pain control similar to a continuous FNB while avoiding 
motor block with its functional impact. This could be beneficial during the rehabilitation 
period. Study patients in this trial did receive PCA over 48 hours, which could have 
influenced pain score results. Furthermore, slightly more females were in the FNB group. 
The sample size in this study was not large enough to accurately assess complication 
rates. It also appears that not all patients completed postoperative functional outcomes 
but this was not addressed in the discussion of the paper.  
A small but potentially important increase in the rates of serious infection in patients 
receiving continuous local infiltration through catheratization, was found in a meta-
analysis conducted by Marques et al. within TKA patients73,80. Therefore, though FNBs 
may negatively affect quadriceps function, are time-consuming, and are associated with 
complications, it still remains the most commonly used peripheral nerve block method. 
However, the potential and functional benefits of PAI versus FNB remain controversial 
and are still being investigated3.  
2.7  Summary  
The TKA is a surgical procedure that results in the best outcomes for osteoarthritis of the 
knee. Postoperative TKA pain is severe and can negatively affect patient satisfaction, 
functional outcomes, and the duration of hospitalization. Therefore, aggressive and 
effective pain control during the early postoperative period is essential. Traditional 
analgesic techniques such as PCA, epidurals, LPBs, and FNBs have been performed to 
improve postoperative recovery. Though PCA using intravenous opioids and continuous 
epidurals provide effective analgesia, they can be associated with side effects such as 
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nausea, pruritus, vomiting, dizziness, urinary retention, sedation, poor muscle control, 
and constipation. LPBs require advanced skills to perform and FNBs can negatively 
affect quadriceps function increasing risks for inpatient falls.  
Recently, studies that investigated adductor canal blocks have shown them to be effective 
nerve blocks, providing adequate analgesia and sparing quadriceps strength in the early 
postoperative period. More specifically, single injection adductor canal blocks do not 
carry the risks associated with catheter use. Furthermore, using single injection 
periarticular infiltrations as a regional block technique is simple to administer, spares 
quadriceps strength, and provides adequate analgesia. FNBs are the most commonly used 
blocks and studies consistently compare them to adductor canal blocks or periarticular 
infiltration techniques. However, currently no clinical trial has directly compared 
adductor canal blocks to periarticular infiltrations. Therefore, a randomized clinical trial 
is needed to directly compare functional outcomes, pain, length of stay, and narcotic 
consumption directly following a TKA between these two interventions.  
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Chapter  3    
3   Objectives    
Our primary objective was to compare the duration of analgesia following total knee 
arthroplasty in patients who received periarticular infiltration to those who received a 
motor sparing knee block. Our secondary objectives were to compare the two analgesic 
techniques for the following outcomes: function using the Western Ontario McMaster 
Osteoarthritis Index, Timed Up and Go, eligibility to perform physiotherapy, quadriceps 
muscle power, length of hospital stay, and time to and length of first mobilization; pain 
using a Numerical Rating Scale, time to rescue analgesia, total opioid consumption, and 
site of predominant pain; quality of life using the Short Form 12; satisfaction, and side 
effects. 
We hypothesized that the motor sparing knee block would provide no difference in 
analgesia duration compared to patients who receive periarticular local infiltration 
analgesia following total knee arthroplasty. We also hypothesized that function, pain, 
quality of life, satisfaction, side effects, and length of stay would be similar between the 
two groups. 
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Chapter  4    
4   Materials  and  Methods    
4.1  Study  Design  
This was a single-centre randomized clinical trial that took place in London, Ontario at 
the London Health Sciences Centre (LHSC), University Hospital between July 2014 and 
June 2015. The study involved patients undergoing a primary total knee arthroplasty 
(TKA). The study was approved by the University of Western Ontario Research Ethics 
Board for Health Sciences Research Involving Human Subjects (Appendix A). 
4.2  Eligibility  Requirements    
Eligible patients were those between the ages of 18 and 85 years scheduled to undergo 
elective primary TKA at the LHSC University Hospital, with good contralateral leg 
strength and an ASA class between one and three. Patients were ineligible if they were 
being hospitalized for reasons other than the planned surgery; had a psychiatric illness or 
cognitive impairment that precluded them from giving informed consent or rendered the 
patient unable to complete questionnaires; narcotic dependency; extraneous sources of 
chronic pain; an allergy to any of the study drugs; any contraindications to blocks or 
multimodal analgesia; patients who were wheelchair bound; patients with a language 
barrier; or those unwilling to provide informed consent.  
4.3  Subject  Recruitment    
Patients were recruited from the practices of four orthopaedic surgeons who specialize in 
joint arthroplasty at the LHSC in London, Ontario. 
4.4  Randomization  
Eligible patients were randomized via web-based software 
(www.empowerhealthresearch.ca) prior to their TKA by one of two graduate students not 
involved in the assessment of outcomes. The randomization contained mixed block sizes 
of two and four and a one-to-one allocation ratio into either (1) motor sparing block 
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(experimental) or (2) periarticular infiltration (control). Randomization was stratified by 
gender and by surgeon.   
4.5   Interventions  
4.5.1  Motor  Sparing  Block  (experimental  group)  
A pre-procedural scan performed by the anesthesiologist identified suitable locations to 
perform the three major block injections. MSB blocks were performed in the PACU 
block room using standard preoperative monitors including electrocardiogram (ECG), 
pulse oximeter, and noninvasive blood pressure monitoring. Following sterile 
precautions, the skin was anesthetized with 1% lidocaine. Patients were sedated during 
the administration of the block with midazolam and fentanyl at the discretion of the 
anesthesiologist performing the block. The MSB was performed under ultrasound 
guidance in the supine position with the leg in external rotation. The MSB included 0.5% 
ropivacaine, 2.5 ug/mL of epinephrine, 10 mg of morphine, and 30 mg of ketorolac 
giving a total anesthetic volume of 60 mL. The motor sparing block consisted of three 
stages; the posterior peri capsular injection, adductor canal blockage, and lateral femoral 
cutaneous injection to provide full knee analgesia.   
4.5.1.1   Posterior  Peri  Capsular  Injection  
An eight-centimeter block needle was inserted near the medial femoral epicondyle (10 
centimeters from the joint line) under ultrasound guidance. At this site, 20 mL of the 
study drug was injected between the bone and popliteal artery. This constituted the 
posterior peri capsular injection.  
4.5.1.2   Adductor  Canal  Blockage  
The femoral artery was traced from the groin region under the sartorius muscle until the 
superior geniculate artery was seen to take off from the femoral artery. The probe was 
rotated 900 and moved superior tracing the sartorius and the femoral artery eight to ten 
centimeters proximally in the long axis. This was marked as the second needle entry 
point for injection of the intermediate cutaneous nerve. The intermediate cutaneous nerve 
of thigh usually travels as a dual nerve between the sartorius and rectus femoris above the 
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fascia lata, which was identified at this point. An eight-centimeter block needle was 
inserted out of plane with the artery in short axis under the sartorius at the pre-marked 
site. Between the sartorius and rectus femoris muscles, 5 mL of study drug was injected 
to target the intermediate cutaneous nerve of the thigh. For this injection the needle was 
inserted from a lateral to medial direction with the needle tip lying superficial to the 
fascia lata. The needle was redirected to enter the fascia of the sartorius to deliver an 
additional 5 mL of the study drug. The needle was then advanced until the needle tip was 
seen to lie adjacent to the femoral artery under the sartorius within the adductor canal. 
Following this, 20 mL of the study drug was injected, while watching for confirmation of 
the study drug deposition around the femoral artery. A block catheter was inserted three 
centimeters beyond the tip of the needle under ultrasound guidance. Colour Doppler was 
used to confirm that the catheter tip was in the proper location (close to the femoral 
artery). Therefore, a total of 30 mL of the study drug solution was used in the adductor 
canal blockage.  
4.5.1.3   Lateral  Femoral  Cutaneous  Injection    
Following the adductor canal block, the sartorius was traced to its origin at the anterior 
superior iliac spine. The lateral cutaneous nerve of thigh was blocked in the lacuna 
musculorum between the origin of sartorius and tensor fascia lata muscle with the final 
10 mL of the study drug. Therefore, a total study drug volume of 60 mL was used. Sham 
periarticular injections of isotonic saline (100 mL) were administered intraoperatively to 
blind both the surgeon and anesthesiologist.  
4.5.2  Periarticular  Infiltration  (control  group)  
Patients randomized to the control group had isotonic saline (60 mL) injected during the 
preoperative performance of the MSBs to ensure blinding. These patients received 
periarticular infiltration of local anesthetics. This 100 mL mixture consisted of 0.3% 
ropivacaine, 2.5 µg/mL of epinephrine, 10 mg of morphine, and 30 mg of ketorolac 
administered by the surgeon at the end of surgery as per usual practice at LHSC. The first 
20 mL aliquot of the mixture was injected into the posterior aspect of the capsule and the 
medial and lateral collateral ligaments just prior to implantation of the component. Care 
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was taken around the area of the common peroneal nerve during this process. The 
quadriceps mechanism and retinacular tissues were then infiltrated with an additional 20 
mL of the study drug. Finally, the remaining 60 mL was used to infiltrate the fat and 
subcuticular tissues.   
4.5.3  Standardization  of  Potential  Co-­interventions  
All study patients received preoperative multimodal analgesia of Tylenol (975mg), 
Naproxen (500mg), Gabapentin (600mg), and Granisetron (2mg). All TKA’s were 
posterior stabilized using one of the following implants; Attune, Triathlon, or Genesis II. 
Patellar resurfacing was performed at the discretion of the surgeon. Surgery was 
performed in a bloodless field using a femoral tourniquet. At the end of surgery, the 
surgeon applied compression bandages covering the entire knee. All patients received 
spinal anesthesia with 15 mg of hyperbaric bupivacaine with titrated sedation 
intraoperatively at the discretion of the anaesthesiologist.  
Following surgery the inpatient drug regimen was standardized. Infusion of local 
anesthetics into the catheter was initiated once patients reported pain of 6/10 or higher on 
the VAS pain scale. This started with a 10 mL bolus of 0.2% ropivacaine and subsequent 
infusion at a basal rate of 6 mL/hour with patient controlled boluses (PCRA) of 4 mL 
every 30 minutes as need. This ensured prolonged analgesia once the single injection 
MSB or PAI interventions stopped providing adequate pain relief. Secondary rescue 
analgesia consisted of five to ten milligrams of oxycodone as needed if pain was still 
poorly controlled. All patients were seen twice a day by ward physiotherapists as per 
standard protocol.  
4.6   Blinding  
An independent anesthesiologist (SG) who was not involved in administering the study 
interventions or conducting outcomes assessments prepared and concealed the study 
drugs from the outcome assessors and the anesthesiologists responsible for performing 
the motor sparing blocks, and the orthopaedic surgeons performing the infiltrations. An 
independent nurse not involved in the study measured the block characteristics. Therefore 
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the patient, surgeon, block anesthesiologist, and outcome assessor all remained blinded. 
Block mixtures and isotonic saline are visually indistinguishable. Furthermore, the 
containers were identical in appearance. Patients who were randomized to receive 
preoperative motor sparing blocks (MSB) received intraoperative periarticular 
infiltrations (PAI) with isotonic saline. Patients who were randomized to receive PAIs 
received preoperative MSBs with isotonic saline.  
4.7   Outcome  Measures  
All patients were measured preoperatively, every day during their inpatient stay until 
discharge, and at three months postoperatively.  
4.7.1  Primary  Outcome  Measure    
The primary outcome in this study was duration of analgesia. This was measured using a 
numeric pain rating scale (NPRS). The NPRS is an 11-point interval scale from zero (no 
pain) to ten (worst pain imaginable). A review paper by Williamson et al.82 indicated that 
the 11-point interval scaled NRPS has a high sensitivity to change; is reliable, valid, and 
easy to administer. Time zero was defined as the end of the administration of the MSB by 
the anaesthetist or completion of PAI by the surgeon. Patients were assessed for pain 
during rest and activity (45 degrees of flexion) at baseline, upon arrival in PACU, and 
then at two, four, six, 12, 18, 24, 30, 36, and 48 hours. If patients were not discharged at 
or before 48 hours, pain was assessed at 72 hours. If patients were discharged before 48 
hours, the research assistant telephoned the patient and asked them to verbally report their 
pain scores at 48 hours.   
The end of analgesia was defined as patient reported pain equal to or more than 6/10 on 
the NRPS. Additional studies have used pain equal to or more than 6/10 on the NRPS as 
an indicator for severe pain as well 11,59. The first rescue analgesia was the initiation of 
the continuous ACB (10 mL bolus of 0.2% ropivacaine and subsequent infusion at a 
basal rate of 6 mL/hour with patient controlled boluses of 4 mL every 30 minutes as 
needed) by the bedside nurse for the purpose of controlling pain.  We reported the 
proportion of patients who were discharged prior to starting the first rescue analgesia. 
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4.7.2  Secondary  Outcome  Measures    
4.7.2.1   Quadriceps  Muscle  Strength  
We measured maximum voluntary isometric contraction (MVIC) with a hand held 
dynamometer (JTECH Medical; Commander Echo Muscle Testing Dynamometer) before 
and 20 minutes after the administration of the blocks. Hand held dynamometers are 
considered reliable and valid instruments83. After surgery, we repeated this measurement 
at six hours after the initial block, and 0800 hours and 1600 hours daily until the 
resolution of the initial block evidenced by NPRS pain equal to six or higher.  
We evaluated quadriceps muscle strength with the patient in a seated position on the edge 
of the bed. The knee was flexed approximately 60 degrees with both feet hanging. The 
hand held dynamometer was placed perpendicular to the tibial crest five centimeters 
proximal to the medial malleolus as described by Grevstad et al.11. For each assessment, 
three measurements were done with a five second pause between measurements. We 
recorded the maximum value out of the three.  
4.7.2.2   WOMAC  
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a 
widely used measure of symptoms and physical disability which was originally 
developed for patients with OA of the hip or knee84. It evaluates clinically important and 
patient-relevant changes in health status as a result of treatment interventions. The 
WOMAC evaluates three dimensions: pain, stiffness, and physical function with five, 
two, and seventeen questions, respectively85. For our study we used the Likert version of 
the WOMAC. Each question is rated on an ordinal scale of zero to five and is associated 
with descriptors; zero (none), one (mild), two (moderate), three (severe), and four 
(extreme). All three sections of WOMAC are summed together and the total score 
indicates the severity of the patients’ pain (0-20), stiffness (0-8), and physical disability 
(0-68). A higher WOMAC score indicates worse pain, stiffness, and physical 
functionality in the individual.  
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McConnell et al.84 conducted a literature review to assess the reliability, validity, and 
responsiveness of the WOMAC using 43 extracted articles. While assessing the reliability 
in a drug trial using the Likert WOMAC they found an internal consistency of the pain 
subscale to be 0.86, 0.90 for stiffness, and 0.95 for physical function. Consistent 
responsiveness was found for all subscales. They concluded that the WOMAC is valid, 
reliable, and sensitive for use in TKA trials. Marsh et al.86 found excellent agreement 
between the paper and electronic versions of the WOMAC (WOMAC ICC= 0.96, 95% 
CI 0.94 to 0.98) concluding that online data collection may be substituted for the 
traditional paper method with no significant effect on the validity of the questionnaires. 
In our study, patients completed the WOMAC questionnaire at baseline and again at three 
months postoperatively. For our results, higher WOMAC scores indicate improved pain, 
stiffness, and physical functionality. 
4.7.2.3   SF-­12  Health  Survey  (SF-­12)  –  version  2  
A shortened version of the SF-36, the SF-12 health survey, is a patient reported survey 
that assesses general health.  The SF-12 consists of two questions concerning physical 
function, two questions on role limitations because of physical health problems, one 
question on bodily pain, one question on general health perceptions, one question on 
vitality (energy/fatigue), one question on social functioning, two questions on role 
limitations because of emotional problems, and two questions on general mental health87. 
These eight weighted sections are each transformed onto a scale of zero to 100 where 
zero indicates the worst disability. The SF-12 health survey has been proven to be a valid, 
reliable, and responsive outcome measure.88 Study patients completed the SF-12 
questionnaire at baseline and again at three months postoperatively.  
4.7.2.4   Physiotherapy  and  Mobilization      
We recorded when patients reached eligibility to perform their first inpatient 
physiotherapy appointment following TKA. Furthermore, time to first mobilization and 
pain on the NPRS following every physiotherapy appointment was recorded. For our 
study, only a walking distance greater than five meters was considered patient 
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mobilization.  We recorded length of the first mobilization and if a study patient was 
unable to perform physiotherapy.  
4.7.2.5   Total  Opiate  Consumption  
We recorded the time each rescue medication was received, dose, and frequency. If poor 
pain control persisted after the first two rescues (ACB and oxycodone), the ward nurse 
administered Hydromorph Contin; the same data was recorded (time, dose and 
frequency) by accessing the patients’ medication administration record.   
4.7.2.6   Timed  Up  and  Go  Test  
The timed up and go (TUG) test is a valid and reliable test (ICC=0.80, 95% CI: 0.70, 
0.94) to evaluate patients on an orthopaedic rehabilitation ward on skills in functional 
mobility89,90. The TUG test consists of recording the time it takes for an individual to get 
up from a chair, walk at a comfortable pace to a three-metre mark, turn around, come 
back, and sit back down91. The chair used in all tests was standardized and the assistive 
device used by the study patient during the test was recorded. All patients attempted to 
perform the TUG test during the first physiotherapy appointment on postoperative day 
one (POD1) and again at discharge. If a patient was unable to perform the test it was 
recorded and the reason documented.   
According to Podsialdo et al.91 TUG tests indicate the patients’ level of physical 
mobility. Specifically, independent individuals can perform the test in less than ten 
seconds. Individuals who perform the test in ten to 20 seconds are within normal limits 
for frail elderly patients. Finally, patients who take 30 seconds or more to complete the 
test, require assistance from others for many mobility tasks.  
4.7.2.7   Site  of  Predominant  Pain  
During each pain assessment (two, four, six, 12, 18, 24, 30, 36, 48, and 72 hours if 
needed) patients were asked to indicate where on their knee they felt the most intense 
pain.  
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4.7.2.8   Side  Effects  
During each assessment until discharge (two, four, six, 12, 18, 24, 30, 36, 48, and 72 
hours if needed) we recorded intensity of nausea and incidence of pruritus. Patients used 
a four-point scale to evaluate nausea at each time point (0= no nausea or vomiting, 
1=nausea no vomiting, 2=vomiting, 3=persistent vomiting)53,13,62,92 and  pruritus (yes or 
no).  
4.7.2.9   Length  of  Hospital  Stay    
We recorded the number of days until patients reached discharge eligibility. Patients were 
discharged by their attending surgeon and physiotherapist when pain and nausea were 
controlled, there was an absence of medical or surgical complications, and if they were 
mobile and able to manage stairs.  
4.7.2.10   Patient  Satisfaction    
Study patients were given a satisfaction form to complete when discharge eligibility was 
achieved and again at three months postoperative. This form included the patient 
satisfaction section from the post-operative Knee Society Score (KSS) questionnaire and 
an additional question that recorded the patients’ overall satisfaction with their 
postoperative pain control using a NRS from zero (very poor) to ten (very good)13,93. The 
KSS is a validated and reliable questionnaire that combines an objective physician-
derived component with a subjective patient-derived component that evaluates pain 
relief, functional abilities, satisfaction, and fulfillment of expectations94,95. The patient 
satisfaction section contains five questions on a forty-point scale.  
4.7.2.11   Patient  Characteristics  and  PACU/Block  Room  Details  
Preoperatively, we collected demographic information including birthdate, operative 
knee, gender, height, weight, BMI, comorbidities, and usual pain medications. While the 
patients were in the PACU and block room, the research team collected details including 
date of surgery, ASA score, block sedation requirement, pre-op pain score (rest/activity), 
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pre-op multimodal drugs given, block performance time, number of injection attempts, 
block failure, colour doppler, time of intraoperative infiltration, block sensation testing, 
patient proprioception, time of spinal recession, and intra-operative analgesics.  
4.8   Sample  Size  
According to Zhang et al.16 the duration of analgesic effect from single injection PAI 
(control group) can range from eight to 24 hours. In an unpublished pilot study, clinicians 
at LHSC claimed experiencing a mean duration (±SD) of single injection PAI analgesia 
to be approximately 16 (±5.5) hours. They also defined the minimally important 
difference between groups in analgesic duration to be four hours. Clinicians at LHSC 
chose this number based on their experiences since it was not available in the literature. 
We conducted a formal equality sample size calculation using a two-sided alpha error 
rate of 0.05 with a statistical power of 80% to detect a minimally important difference 
between groups of four hours. We used the pre-determined standard deviation of ±5.5 
hours in this calculation. This required approximately 30 patients to each group. We 
expected a 20% dropout rate. Therefore, we chose to recruit 80 patients for the trial, 40 to 
each group.  
4.9   Data  Analysis  
We analyzed all patients according to the treatment arm they were assigned to (intention-
to-treat). We used SPSS version 23.0 to perform the analysis of the data. We used 
descriptive statistics to present the demographic characteristics of each group using 
means and standard deviations for continuous variables (age, height, weight, and BMI) 
and proportions for nominal variables (sex, operative knee, ASA score, tourniquet time, 
and medications).  
We used an analysis of covariance (ANCOVA) to statistically compare the two groups 
for total duration of analgesia, quadriceps strength, WOMAC, time to eligibility for 
physiotherapy, time to and length of first mobilization, time to complete the TUG tests, 
SF-12, length of stay, satisfaction, opiate consumption, and physiotherapy pain. The 
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outcome served as the dependent variable, group allocation served as the independent 
variable and pain and tourniquet time as the covariate. Baseline scores were used as 
covariates for WOMAC and SF-12. If the data was not normally distributed we used the 
Mann-Whitney U test to statistically compare the groups. A Bonferroni correction was 
used to correct for multiple comparisons.  
We reported the unadjusted mean with 95% confidence intervals in figures and the 
adjusted mean with standard error and the adjusted mean difference between groups with 
95% confidence intervals in tables and text. We used the last outcome carried forward 
(LOCF) method in patients whose final pain score was missing (n=3).   
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Chapter  5    
5   Results  
5.1   Participant  Flow    
The flow of patients through each stage of the study is outlined in Figure 5. From July 
2014 to March 2015, we screened 334 patients for this study. Of these, 138 patients were 
ineligible, 16 were missed, 22 declined to participate, and 59 were enrolled in other 
studies. Several patients were excluded for more than one reason.  
Eighty-eight eligible patients gave their consent to participate in the study. Five patients 
were withdrawn prior to being randomized for surgery; four patients decided not have to 
surgery during the study time and one patient was rescheduled without study assessors 
being notified. Twelve patients were withdrawn after being randomized. Of these, five 
withdrew consent because they no longer wanted to undergo a spinal anesthetic, three 
patients withdrew because they felt the risks associated with undergoing a block were too 
high, one patient rescheduled their surgery outside of the study period, there was 
insufficient time to perform the intervention for one patient, and for two patients first 
rescue was erroneously initiated immediately post surgery. At the time of this analysis, 
54 patients had reached the three-month study end point.  Patient demographics and 
comorbidities were similar between groups (Table 1).  
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Some patients ineligible for more than one reason. 
Assessed for Eligibility (n=334) 
Ineligible (n=138) 
Age (n=4) 
Not scheduled to undergo primary TKA 
(n=11) 
Significant contralateral leg weakness 
(n=19) 
Planned hospitalization for other reasons 
(n=1) 
Psychiatric illness (n=9) 
Revision surgery (n=1) 
Narcotic dependency (n=4) 
Pre-existing chronic pain (n=18) 
Study drug allergies (n=26) 
Contraindications to blocks (n=63) 
Wheelchair bound (n=4) 
Language barrier (n=7) 
Enrolled in another study (n=59) 
Cancelled appointment (n=11) 
Declined to participate (n=22) 
Missed (n=16) 
 
 
 
 
 
 
 
 
 
 
 
 
Eligible (n=87) 
Pre-randomization 
withdrawal (n=5) 
Randomized 
(n=82) 
Motor Sparing 
Knee Block (n=41) 
Periarticular 
Infiltration (n=41) 
Withdrawn at 
hospital visit (n=6) 
Withdrawn at 
hospital visit (n=6) 
Included in hospital 
stay analysis (n=35) 
Included in hospital 
stay analysis (n=35) 
Reached 3 months 
(n=30) 
Reached 3 months 
(n=24) 
Included in 3 month 
analysis (n=30) 
Included in 3 month 
analysis (n=24) 
Figure 5: Participant flow through study 
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Table 1: Baseline Demographics for patients undergoing total knee arthroplasty with 
either the motor sparing block or periarticular infiltration techniques 
Characteristic Motor Sparing 
Knee Block 
(n=41) 
Periarticular Infiltration 
(n=41) 
Male, n (%) 13 (31.7) 15 (36.6) 
     Mean Age ± SD, y 68±8 63±9 
Mean Height ± SD, cm 165 ±10 167 ±10 
Mean Weight ± SD, kg 95±22 91±21 
Mean BMI ± SD, kg/m2 34.6±7.7 32.4±7.1 
Operative Knee, Right n (%) 25 (61) 25 (61) 
ASA Status, n (%) 
One  
Two 
Three  
 
2 (4.9) 
23 (56.1) 
16 (39.0) 
 
0 (0) 
26 (63.4) 
15 (36.6) 
Tourniquet Time ± SD, min 70.2 ± 14.5 64.6 ± 10.5 
Pre-Surgical Pain Medications, n (%) 
NSAIDS 
Pain Killers 
Narcotics 
 
22 (53.7) 
23 (56.1) 
10 (13.7) 
 
20 (48.8) 
18 (43.9) 
8 (19.5) 
Abbreviations. SD = standard deviation, BMI = body mass index, ASA = American Society 
of Anesthesiologists physical status classification system, MSB=motor sparing block, PAI= 
periarticular infiltration 
The time to perform the block and method of sedation were similar between groups as were 
other means of intraoperative pain management (Table 2). 
Table 2: Block characteristics for patients undergoing total knee arthroplasty with 
either the motor sparing block or periarticular infiltration techniques 
Block Characteristics  MSB (n=35) PAI (n=35) 
MSB Performance Time ±SD, min 10.09 ± 3.76 10.74 ± 4.64 
Block Sedation 
   Fentanyl ± SD, ug 
   Midazolam ± SD, mg 
 
85.0 ± 41.2 
1.75  ± 0.38 
 
88.2 ± 35.2 
1.53 ± 0.38 
Intraoperative Propofol ± SD, mg 196.6 ± 113.4 197.1 ± 99.5 
Postoperative Spinal Length ± SD, hrs 1.33 ±1.03 1.06 ±0.82 
Spinal Failure, n (%)  1 (3) 1 (3) 
Abbreviations. SD = standard deviation, MSB=motor sparing block, PAI= periarticular 
infiltration 
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5.2   Primary  Outcome  Measure  
5.2.1   Total  Duration  of  Analgesia    
There was a statistically significant difference between groups in the total duration of 
analgesia during hospitalization (8.8 hours (95% CI 3.98 to 13.62), p<0.01) in favour of the 
MSB with a mean duration of 18.06 ±1.68 hours compared to the PAI group with a mean 
duration of 9.25 ± 1.68 hours. The distribution of the PAI group was more skewed towards 
lower duration hours in comparison to the MSB group with lines representing mean values 
(Figure 6). 
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Figure 6: Total duration of analgesia following total knee arthroplasty with either the 
motor sparing block or periarticular infiltration block techniques (dark line: 
medians)  
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5.3   Secondary  Outcome  Measures  
5.3.1   Overall  Pain  
5.3.1.1   Pain  at  Rest    
There was a statistically significant difference in mean pain scores at rest at two hours 
postoperative. There were no significant differences at any other time points (Figure 7).  
Eighteen patients remained in the hospital at the 72 hour time point (MSB n=9, PAI n=9).  
 
Figure 7: Numerical rating pain scores at rest following TKA with either the motor 
sparing block or periarticular infiltration block techniques (unadjusted 
means, 95% confidence intervals) 
 
5.3.1.2   Overall  Pain  During  Activity    
There was a statistically significant difference in pain scores during activity at two and four 
hours postoperative. There were no significant differences at any other time points (Figure 
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8).  Eighteen patients remained in the hospital at the 72 hour time point (MSB n=9, PAI 
n=9).  
 
Figure 8: Numerical rating pain scores during activity following TKA with either the 
motor sparing block or periarticular infiltration block techniques 
(unadjusted means, 95% confidence intervals) 
5.3.2   Quadriceps  Muscle  Strength    
Because quadriceps strength was measured at baseline, 20 minutes and six hours after the 
administration of blocks, and at 0800 hours and 1600 hours daily until the first rescue 
analgesic was received, some patients completed a greater number of muscle tests than 
others because of different rescue times. During the study period no patient required muscle 
testing after 0800 hours on postoperative day two because they had been discharged from 
hospital. 
There were also no statistically significant differences for quadriceps muscle strength in 
pounds of force between groups preoperatively (adjusted mean difference -1.23 (95%CI -
9.14 to 6.61), p=0.75) or at 20 minutes (adjusted mean difference -0.41 (95%CI -7.60 to 
6.78), p=0.91) and 6 hours postoperatively (adjusted mean difference -1.23 (95%CI -6.8 to 
4.3), p=0.66) (Figure 9).  No significant differences were found at further time points. 
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Figure 9: Quadriceps muscle strength in pounds of force following total knee 
arthroplasty with either the motor sparing block or periarticular infiltration 
block techniques (unadjusted means, 95% confidence intervals) 
5.3.3   Western  Ontario  McMaster  Osteoarthritis  Index  
There were no statistically significant differences between the groups at baseline or three 
months for the pain, stiffness, and function domains. Furthermore, no significant differences 
were found between the groups at baseline or three months for the total WOMAC score 
(Table 3). Both groups improved from baseline to three months postoperative. 
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Table 3: Western Ontario McMaster Osteoarthritis Index scores following total knee 
arthroplasty with either the motor sparing block or periarticular infiltration block 
techniques (adjusted means) 
Time Domain MSB  
(mean ± SE) 
PAI 
 (mean ± SE) 
Adjusted Mean  
Difference (95% CI) 
p-Value 
Preop Pain 54.2 ± 3.09 48.5 ± 2.64  
Stiffness 42.2 ± 4.11 39.2 ± 2.86 
Function 51.2 ± 3.58 50.1 ± 2.68 
Total 50.5 ± 3.07 47.1 ± 2.38 
3m Pain 77.8 ± 3.23 72.7 ± 2.88 -5.08 (-13.8 to 3.7) 0.25 
Stiffness 62.7 ± 3.99 57.3 ± 3.57 -5.41 (-16.2 to 5.4) 0.32 
Function 75.0 ± 3.14 72.1 ± 2.81 -2.87 (-11.4 to 5.6) 0.49 
Total 73.3 ± 2.75 69.5 ± 2.46 -3.80 (-11.2 to 3.6) 0.31 
Abbreviations. SE = standard error, CI = confidence interval, MSB=motor sparing block, 
PAI= periarticular infiltration 
5.3.4   SF-­12  Health  Survey  (SF-­12)  –  version  2  
There were no statistically significant differences found between the groups at baseline or 
three months for the physical or mental components (Table 4).  Both groups improved from 
baseline to three months for the physical component.  
Table 4: SF-12 Health Survey scores following total knee arthroplasty with either the 
motor sparing block or periarticular infiltration block techniques (adjusted 
means) 
Time Domain MSB  
(mean ± SE) 
PAI 
 (mean ± SE) 
Adjusted Mean  
Difference (95% CI) 
p-Value 
Preop Mental 57.9 ± 2.02 54.0 ± 1.96  
Physical 31.5 ± 1.56 32.2 ± 1.71 
3m Mental 51.9 ± 1.67 55.1 ± 1.48 3.16 (-1.24 to 7.65) 0.17 
Physical 43.5 ± 1.53 39.8 ± 1.37 -3.75 (-7.87 to 0.37) 0.07 
Abbreviations. SE = standard error, CI = confidence interval, MSB=motor sparing block, 
PAI= periarticular infiltration 
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5.3.5   Physiotherapy  and  Mobilization    
5.3.5.1   Time  to  Eligibility  for  Physiotherapy    
The time it took patients to reach eligibility to perform their first inpatient physiotherapy 
following TKA was not significantly different between the groups (0.34 hours (95% CI -
1.37 to 2.05), p=0.69). It took patients in the MSB group a mean of 20.7 ± 0.59 hours and 
patients in the PAI group a mean of 20.4 ± 0.59 hours.  
5.3.5.2   Time  to  First  Mobilization  
The length of time it took patients to mobilize for the first time following TKA was not 
significantly different between groups (2.2 hours (95% CI -4.2 to 8.6), p=0.49). It took 
patients in the MSB group a mean of 27.3 ± 2.23 hours and patients in the PAI group a mean 
of 25.0 ± 2.23 hours.  
5.3.5.3   Length  of  First  Mobilization    
The length of first mobilization following TKA was not significantly different between 
groups (0.5 meters (95% CI -0.69 to 1.71), p=0.40). Patients in the MSB group mobilized 
for a mean of 8.23 ± 0.42 meters compared to patients in the PAI group who mobilized for a 
mean of 8.74 ± 0.42 meters.  
5.3.5.4   Physiotherapy  Pain  
The number of patients remaining in hospital decreased over time. Thus, the number of 
patients participating in inpatient physiotherapy also decreased. Other than being 
discharged, two patients in the PAI group did not undergo physiotherapy on the morning of 
postoperative day one (too nauseous); three patients did not participate in physiotherapy on 
the afternoon of postoperative day one (significant pain (n=2) and no physiotherapist 
available (n=1)); one did not perform physiotherapy on the morning of day two (too 
nauseous).  There was no difference between groups for the amount of pain immediately 
following each physiotherapy appointment (Figure 10). 
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Figure 10: Pain following postoperative physiotherapy appointments following total 
knee arthroplasty with either the motor sparing block or periarticular 
infiltration block techniques (unadjusted means, 95% confidence intervals) 
5.3.6   Total  Opiate  Consumption    
There were no differences in total oxycodone consumption (Figure 11) or total 
hydromorphone consumption  (Figure 12) between the two groups at any time point. 
Eighteen patients remained in the hospital at the 72 hour time point (MSB n=9, PAI n=9).  
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Figure 11: Oxycodone consumption following total knee arthroplasty with either the 
motor sparing block or periarticular infiltration block techniques 
(unadjusted means, 95% confidence intervals) 
 
Figure 12: Hydromorphone consumption following total knee arthroplasty with either 
the motor sparing block or periarticular infiltration block techniques 
(unadjusted means, 95% confidence intervals) 
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5.3.7   Timed  Up  and  Go  Test  
A total of 18 study patients could not perform the TUG test on postoperative day one. Eight 
of these patients were in the MSB group and ten were in the PAI group. One patient in the 
PAI group used crutches to complete the test while all patients in the MSB group used a 
walker. No statistically significant differences were found between groups for time to 
complete the TUG on postoperative day one (Table 5).  
One patient in the MSB group refused to perform the TUG test at discharge because of 
muscle weakness and a fear of falling. Four patients in the PAI group used crutches to 
complete the test while all patients in the MSB group used a walker. No statistically 
significant difference was found between groups for time to complete the TUG at discharge 
(Table 5).  
Table 5: Time to Complete the Timed Up and Go in seconds following total knee 
arthroplasty with either the motor sparing block or periarticular infiltration 
block techniques (adjusted means) 
Time 
  
MSB  
(mean ±SE) 
PAI  
(mean ± SE) 
Adjusted Mean 
Difference (95% CI) 
p-Value 
Day 1 
nMSB=27,nPAI=25 
66.16 ±3.52 58. 48 ± 3.66 
 
-7.69 (-17.92 to 2.54) 0.14 
Discharge 
nMSB=34, nPAI=35 
50.21 ±3.68 
  
47.51 ± 3.62 
 
-2.69 (-13.02 to 7.63)  0.60 
Abbreviations. SE = standard error, CI = confidence interval, MSB=motor sparing block, 
PAI= periarticular infiltration 
5.3.8   Site  of  Predominant  Pain  
There was no statistically significant relationship between group allocation and site of 
predominant pain at any of the time points. Nine patients in the MSB group and nine 
patients in the PAI group remained in the hospital at 72 hours. From arrival in PACU to two 
hours postoperative most patients did not report pain in their knee. At four hours 
postoperative, approximately half of the MSB group reported pain at the front of their knee 
whereas the other half still reported no pain. At this same time, about a quarter of the PAI 
patients reported pain at the front of their knee, another quarter reported pain at the back of 
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the knee whereas about half still reported no pain. From six hours postoperative until 
discharge the most common site of predominant pain for each group was at the front of the 
knee.  
5.3.9   Side  Effects  
5.3.9.1   Nausea  
There were no differences in nausea scores between treatment groups from zero to 72 hours 
(Figure 13). 
 
Figure 13: Nausea scores following total knee arthroplasty with either the motor 
sparing block or periarticular infiltration block techniques (unadjusted 
means, 95% confidence intervals) 
5.3.9.2   Pruritus    
There was no difference between groups for pruritus at any of the time points. At majority of 
time points, no patients reported pruritus.  
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5.3.10   Length  of  Hospital  Stay  
The length of hospital stay following TKA was not significantly different between groups 
(0.23 days (95% CI -0.19 to 0.66), p=0.29). Patients in the MSB group had a mean hospital 
stay of 2.39 ± 0.15 days compared to patients in the PAI group who had a mean hospital stay 
of 2.17 ± 0.15 days.  
5.3.11   Satisfaction  
Overall NRS satisfaction with overall pain control from surgery until discharge was not 
significantly different between groups at discharge (adjusted mean difference -0.20 (95%CI 
-1.62 to 1.22), p=0.77). KSS satisfaction scores were also not significantly different between 
groups at discharge or three months (Table 6). 
Table 6: Knee Society Score Satisfaction following total knee arthroplasty with either 
the motor sparing block or periarticular infiltration block techniques 
(adjusted means) 
Time 
  
MSB  
(mean ±SE) 
PAI  
(mean ± SE) 
Adjusted Mean 
Difference (95% CI) 
p-Value 
Discharge 21.2 ± 0.92 20.2 ± 0.86 0.23 (-371 to 4.17) 0.91 
3m 28.4 ± 1.43 28.6 ± 1.33 0.05 (-0.95 to 1.05) 0.93 
 
5.4       Adverse  Events    
Three adverse events occurred during this study; two in the MSB group and one in the PAI 
group. One patient in the MSB group suffered a deep vein thrombosis (DVT) that delayed 
their discharge from the hospital. A second patient in the MSB group was admitted to 
emergency for shortness of breath within the three-month study period after their initial 
discharge following TKA. They were discharged from the emergency room with suspected 
interstitial lung disease. One patient in the PAI group fell on the day after surgery attempting 
to get out of bed without assistance. This event did not affect the patients’ rehabilitation and 
they were discharged without delay on day two from the hospital.  
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Chapter  6  
6   Discussion  
We aimed to compare the duration of analgesia following total knee arthroplasty in 
patients who were randomized to receive either periarticular infiltration (control group) 
or a motor sparing knee block (experimental group). We also assessed postoperative 
function, pain, satisfaction, opiate consumption, and side effects.  We found a statistically 
significant difference in favour of the motor sparing block (MSB) group for total duration 
of analgesia and early pain scores during rest and activity (2 to 4 hours) were 
significantly lower in the MSB group. No significant differences were found between 
treatment groups for any other outcome.  
Currently, femoral nerve blocks (FNB) are the gold standard peripheral nerve block for 
TKA at most centers around the world33. At our center however, PAI is the standard 
postoperative analgesia because it spares quadriceps function thereby facilitating 
rehabilitation and a shorter length of stay.  PAI does not however, offer the duration of 
analgesia offered by a FNB15. On the other hand adductor canal blocks (ACB) minimally 
affect quadriceps function but are technologically more challenging than the PAI and 
require ultrasound guidance like the FNB. To date there is one study showing greater 
early postoperative pain relief in favour of FNB1 and six studies showing no difference11–
14,20,96.  There are no studies that demonstrate greater pain relief for the ACB over the 
FNB.   
For our study, we created the MSB that is essentially an ACB with the addition of 
injected analgesia at the posterior and lateral knee joint (posterior periscapular and lateral 
femoral cutaneous nerve injection) with the goal of providing pain relief for more regions 
around the knee joint. Since no study has ever reported duration of ACB, we were 
uncertain whether our MSB would provide a greater duration of pain relief compared to a 
PAI. We did not expect to find differences in quadriceps strength or function between 
MSB and PAI since both techniques retain quadriceps function.  Our longer term goals 
are to enhance the MSB by adding a sedative as an adjuvant to prolong the duration of 
analgesia and avoid the use of the catheter required for continuous infusion blocks. 
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There are no published studies comparing single injection ACBs, which are most similar 
to our MSB technique, to single injection PAI. However, numerous trials have compared 
either single or continuous PAI to FNBs3,10,41,79–81. For example, Uesugi et al.15 
randomized 210 patients to either single injection PAI or FNB with an additional sciatic 
block (FNB group). The drug mixture used in their PAI group was similar in class and 
dose to the mixture used in our study. This study was unique in that they also measured 
the duration of analgesia for their treatment groups as we did. They reported that the 
onset of pain in patients who received the PAI was 8.4 ± 9.2 hours post block which is 
similar to our patients who received PAI whose onset of pain was 9.25 ± 10.3 hours post 
block. They demonstrated that the duration of analgesia for patients who received a 
femoral nerve block (FNB) was longer than those who received a PAI (15.3 ± 8.4 hours).  
Given this finding and the similarity between FNB and MSB (both peripheral nerve 
blocks), we expected the patients who received the MSB to experience a greater duration 
of pain relief than patients who receive a PAI.  In fact, our MSB patients did not require 
their first rescue medication for an average of 18.1 ± 10.1 hours post block.  Both groups 
in our study reported a longer duration of analgesia than the patients in the Uesugi study, 
which may be partially explained by the difference in method to measure time to first 
rescue.  Whereas in the Uesugi et al study patients were instructed to press a call button 
when they felt postoperative pain, in our study patients were required to indicate a pain 
score equal to or greater than six on a pain NRS, which may have meant that our patients 
experienced a greater level of pain before being provided with rescue medication.   
In our study, once patients reached NRS pain greater than or equal to six, the continuous 
infusion (first rescue) was started to reduce pain scores. Since this was standardized 
amongst all study patients, we were uncertain whether there would be a difference in 
NRS pain scores at rest or activity from arrival in PACU until discharge because no study 
has ever reported duration of pain relief for an ACB.  What we were able to show, 
however, was that there was a statistically significant difference for postoperative pain 
scores at two and four hours during activity and at two hours during rest in favour of the 
MSB group with no significant differences at any other time points. This finding is likely 
explained by the shorter duration of pain relief (wearing off for most patients by the first 
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eight hours) for the PAI with increasing pain in these patients until first rescue compared 
to maintained pain relief in patients who received the MSB.  
Studies have shown that ACBs retain quadriceps strength to a greater extent than FNBs 
because of the minimal blocking of motor nerves in the ACB procedure. Only the nerve 
to vastus medialis is blocked in the ACB. For example, Kim et al.13 hypothesized that a 
single injection ACB would be superior in quadriceps strength to the FNB in their 
randomized trial. Strength was assessed with a hand held dynamometer at six to eight 
hours, 24, and 48 hours postoperative. They reported superior quadriceps strength in the 
ACB group at six to eight hours postoperative and no significant differences at 24 or 48 
hours. Similarly, Grevstad et al.11 randomized 50 patients to receive either a single 
injection ACB or single injection FNB. Quadriceps strength was assessed at two hours 
post block. They reported 20% greater quadriceps strength in the ACB group compared 
to the FNB group. Finally, Jaeger et al.92 randomized 54 patients comparing continuous 
ACB to continuous FNB. They assessed quadriceps strength preoperatively and at 24 
hours postoperatively. Their results indicated significantly greater quadriceps strength in 
the ACB group compared to the FNB group.  On the other hand, Wang et al.78 conducted 
a meta-analysis on 10 RCTs comparing PAIs and FNBs. Three studies indicated that the 
number of patients able to do active straight leg raises at 24 hours following TKA was 
significantly larger in the PAI group. Since the two additional injections used in our MSB 
do not target any additional motor nerves, we did not expect to see any differences 
between the MSB and PAI for quadriceps strength in our study. 
In our study, muscle strength was only assessed until the first rescue analgesia was 
received (pain ≥6). This gave us the ability to directly attribute the quadriceps strength 
results to either the MSB or PAI instead of MSB or PAI in combination with any rescue 
medication.  As expected, no statistically significant differences were found between 
groups at any time for quadriceps strength. The number of individuals at each time point 
who had not received the first rescue decreased faster in the PAI group than the MSB 
group.  Only two patients in the MSB group and one patient in the PAI group never 
required rescue medication prior to discharge.  
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In addition to investigating postoperative quadriceps strength in nerve block studies, 
physiotherapy milestones should also be assessed to give a more accurate representation 
of a patient’s overall functional recovery prior to discharge13. In our sample, we did not 
observe differences between groups in time to be eligible to begin physiotherapy (i.e. 
pain control, no nausea) or time to and length of first mobilization. This strengthens our 
conclusion that there was no difference in postoperative functional recovery following 
TKA for the MSB or PAI groups.  Similar to our study, Moghtadeai et al.79 randomized 
40 patients to receive single injection FNB or PAI after TKA. They measured the time to 
first mobilization of greater than or equal to three meters following TKA and found no 
significant differences between groups.  
We did not expect to see a significant difference in TUG test results between the MSB 
and PAI since both interventions are quadriceps sparing techniques. Further, if any 
differences did exist, we would have had to complete the TUG at an earlier time point 
prior to first rescue.  To do this we would have needed a physiotherapist present to safely 
conduct the TUG test prior to first rescue, which was not feasible.  Not surprisingly, there 
were no significant differences in the time to complete the TUG test in either group at 
postoperative day one or discharge. Several studies have reported similar findings14,62,92.  
None were able to conduct the TUG earlier than 24 hours postoperative.  
There were no statistically significant differences in total opiate consumption of 
oxycodone or hydromorphone at any time points up to 72 hours between groups. This 
was not an unexpected finding for our study because we used it as a second rescue, which 
means it is unrelated to the interventions.  However, the amount of opiates consumed in 
our study was lower (0-11 mg) than generally reported (8-30mg)3,41,79 because we used it 
as a second rescue whereas other studies use it as their first rescue.  
There was no statistically significant difference in overall nausea or pruritus between 
groups. We did not expect to see any differences in postoperative side effects since the 
techniques used in both interventions were essentially opiate sparing in turn reducing side 
effects such as postoperative nausea, vomiting, and pruritus4–6,33. In addition, the number 
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of opiates used by study patients was low since the first rescue received was a non-
narcotic (ropivacaine).  
The MSB was designed to provide pain relief for the medial side of the lower leg, the 
posterior, medial anterior, and lateral areas of the knee joint, and lateral thigh. The PAI is 
a local infiltration of the deep tissues of the knee and is not as site specific. Therefore, we 
assumed most patients would complain of pain around the front and slightly above of the 
knee joint prior to first rescue. After their first rescue we expected study patients to also 
complain of pain at the back of the knee since the continuous ACB (first rescue) does not 
provide analgesia for that region. We did think that if there were any differences between 
groups and the location of pain, that these differences would be observed while the PAI 
was wearing off but prior to first rescue. From immediate postoperative up to 6 hours 
postoperative, there was no site of predominant pain; patients reported very little pain. As 
expected, from six hours postoperative until discharge patients indicated that the front of 
the knee was the most painful. This observation was the same for both groups even over 
time, which is most likely related to the placement of the tourniquet and surgical area not 
to the intervention. No other studies evaluating ACBs or PAI as interventions have 
reported the site of predominant pain in patients during the postoperative period.  
As expected, we did not find any statistically significant differences between groups for 
the WOMAC or SF-12 questionnaires since the interventions used in our study exhibit 
their greatest influence on pain and function in the immediate postoperative period 
following TKA up to discharge. We were able to show that patients who received the 
MSB or PAI improved their scores over the duration of the study for pain, stiffness, 
general health, and functionality with no differences between groups. This finding was 
similar to other studies (Bush et al) 
At our institution, it is standard for patients to be discharged on the morning of 
postoperative day two unless pain, muscle weakness, or extensive side effects are 
negatively affecting the patient. Our results showed no statistically significant difference 
between groups in length of stay(LOS) which was expected since both interventions have 
their greatest influence on pain during the early postoperative period. This finding is 
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consistent with other studies3,13,14. Overall NRS satisfaction with pain control at discharge 
was not significantly different between groups. We also recorded satisfaction using the 
satisfaction section on the KSS questionnaire. There were no significant differences 
between groups at discharge or three months. This is consistent with the literature1,13,79.  
Strengths of our study include the randomization of patients to intervention reducing the 
chance of selection bias. We were also able to blind the patient, clinicians and outcome 
assessor reducing expectation and performance biases. Our study is also the first to assess 
the MSB (a modified ACB) for postoperative analgesia following TKA. It is the first 
study to measure duration of analgesia for ACBs and it is the first study to compare 
ACBs to PAIs. 
6.1  Study  Limitations  
Limitations existed in this study including the small sample size, the start and stop time 
points of the duration assessment, and the timing of the TUG test assessment. 
This was a preliminary analysis since some study patients had not reached the three 
month outcome assessments. When total study follow-up is complete, this will provide us 
with further certainty for these results. Furthermore, a number of outcomes were 
continually assessed as patients were discharged or up until first rescue. This caused 
smaller sample sizes for certain outcome time points, and therefore a larger sample size 
would improve precision.  
By using pain greater than or equal to six as the end time for the duration assessment, we 
could of prolonged the duration calculation of both interventions. Patients could of have 
been in postoperative pain but had not received the rescue because their pain had not 
reached six, a level that patients can interpret differently. Instead, the end time could have 
been whenever a patient first felt they needed a rescue. Furthermore, we could of started 
timing the duration of analgesia in both interventions immediately after surgery instead of 
at two different times. This could eliminate the possible advantage of two to three hours 
in duration that the MSB group might have experienced since this intervention was 
completed prior to surgery.  
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Lastly, patients performed the TUG test on the morning of postoperative day one during 
their first physiotherapy appointment. By this time, majority of study patients had already 
received the continuous ACB because of severe pain.  Therefore, our TUG test results are 
not indicative of the mobility ability of patients who exclusively received the PAI or 
MSB. Assessing the TUG test time earlier around six to eight hours postoperative would 
have been more effective.  
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Chapter  7  
7   Conclusion  
The motor sparing block provides significantly longer duration of analgesia than the 
periarticular infiltration while preserving muscle function and not negatively affecting 
length of stay, satisfaction, side effects, or functional rehabilitation.  
7.1  Clinical  Relevance  
Our overall goal is to develop a catheter-free intervention to manage postoperative pain 
that will reduce adverse events like infections, reduce institutional costs, improve ease of 
mobility, and offer a less technologically demanding option for pain management. This 
study is the first step toward achieving this goal by demonstrating that the MSB offers 
similar pain control to a PAI, which has been shown to be similar to the FNB. We were 
also able to confidently demonstrate that the MSB preserves muscle function similar to 
the PAI and better than the FNB.  And finally, we were able to show that the MSB lasts 
longer than the PAI.  Our next step will be to add an adjuvant medication to the MSB to 
prolong the analgesic effects long enough to avoid the catheter required for the usual first 
rescue. 
7.2  Future  Direction  
We will complete data collection for the three month outcomes of our remaining patients. 
This will improve the precision of our results for these outcomes. We will also evaluate 
whether there are significant differences in institutional costs between treatment groups. 
Future directions should assess whether the addition of Dexemedetomidine as an 
adjuvant to the anaesthetic mixture of the motor sparing knee block can prolong the 
duration of analgesia and reduce the need for a catheter dependent continuous block as 
the first rescue. Furthermore, future studies should assess mobilization with the TUG test 
at earlier time points. This would provide an accurate assessment of the postoperative 
mobilization ability of the MSB in comparison to the PAI.  
75 
 
References  
1.  Memtsoudis SG, Yoo D, Stundner O, et al. Subsartorial adductor canal vs femoral 
nerve block for analgesia after total knee replacement. Int Orthop. 2014. 
doi:10.1007/s00264-014-2527-3. 
2.  Memtsoudis SG, Sun X, Chiu Y-L, et al. Perioperative comparative effectiveness 
of anesthetic technique in orthopedic patients. Anesthesiology. 2013;118(5):1046-
1058. doi:10.1097/ALN.0b013e318286061d. 
3.  Chaumeron A, Audy D, Drolet P, Lavigne M, Vendittoli PA. Periarticular 
injection in knee arthroplasty improves quadriceps function knee. Clin Orthop 
Relat Res. 2013;471:2284-2295. doi:10.1007/s11999-013-2928-4. 
4.  Jiang J, Teng Y, Fan Z, Khan MS, Cui Z, Xia Y. The efficacy of periarticular 
multimodal drug injection for postoperative pain management in total knee or hip 
arthroplasty. J Arthroplasty. 2013;28(10):1882-1887. 
doi:10.1016/j.arth.2013.06.031. 
5.  Ganapathy S. Wound/intra-articular infiltration or peripheral nerve blocks for 
orthopedic joint surgery. Curr Opin Anaesthesiol. 2012;25:615-620. 
doi:10.1097/ACO.0b013e328357bfc5. 
6.  R.Sinatra, G.Silverman, S.J.Brull, J.Chung, D.M. Harrison DD. Sinatra Drug 
Article.pdf. Anesthesiology. 1989;71:502-507. 
7.  Maheshwari A V., Blum YC, Shekhar L, Ranawat AS, Ranawat CS. Multimodal 
pain management after total hip and knee arthroplasty at the ranawat orthopaedic 
center. Clin Orthop Relat Res. 2009;467:1418-1423. doi:10.1007/s11999-009-
0728-7. 
8.  Danninger T, Opperer M, Memtsoudis SG. Perioperative pain control after total 
knee arthroplasty  : An evidence based review of the role of peripheral nerve 
blocks. 2014;5(3):225-232. doi:10.5312/wjo.v5.i3.225. 
76 
 
9.  Ilfeld BM, Duke KB, Donohue MC. The association between lower extremity 
continuous peripheral nerve blocks and patient falls after knee and hip 
arthroplasty. Anesth Analg. 2010;111(6):1552-1554. 
doi:10.1213/ANE.0b013e3181fb9507. 
10.  Ashraf A, Raut V V., Canty SJ, McLauchlan GJ. Pain control after primary total 
knee replacement. A prospective randomised controlled trial of local infiltration 
versus single shot femoral nerve block. Knee. 2013;20(5):324-327. 
doi:10.1016/j.knee.2013.04.009. 
11.  Grevstad U, Mathiesen O, Valentiner LS, Jaeger P, Hilsted KL, Dahl JB. Effect of 
Adductor Canal Block Versus Femoral Nerve Block on Quadriceps Strength, 
Mobilization, and Pain After Total Knee Arthroplasty. Reg Anesth Pain Med. 
2015;40(1):3-10. doi:10.1097/AAP.0000000000000169. 
12.  Patterson ME, Bland K, Elliot C, et al. The adductor canal block provides 
analgesia similar to a femoral nerve block in patients undergoing total knee 
arthroplasty-a retrospective study. Reg Anesth Pain Med. 2013;38 (4):1-6. 
doi:10.1016/j.jclinane.2014.08.005. 
13.  Kim DH, Lin Y, Ph D, et al. Adductor Canal Block versus Femoral Nerve Block 
for Total Knee Arthroplasty. Anesthesiology. 2014;120(3):540-550. 
doi:10.1097/ALN.0000000000000119. 
14.  Shah N a., Jain NP. Is Continuous Adductor Canal Block Better Than Continuous 
Femoral Nerve Block After Total Knee Arthroplasty? Effect on Ambulation 
Ability, Early Functional Recovery and Pain Control: A Randomized Controlled 
Trial. J Arthroplasty. 2014;29(11):2224-2229. doi:10.1016/j.arth.2014.06.010. 
15.  Uesugi K, Kitano N, Kikuchi T, Sekiguchi M, Konno SI. Comparison of 
peripheral nerve block with periarticular injection analgesia after total knee 
arthroplasty: A randomized, controlled study. Knee. 2014;21(4):848-852. 
doi:10.1016/j.knee.2014.04.008. 
77 
 
16.  Zhang S, Wang F, Lu ZD, Li YP, Zhang L, Jin QH. Effect of single-injection 
versus continuous local infiltration analgesia after total knee arthroplasty: a 
randomized, double-blind, placebo-controlled study. J Int Med Res. 2011;39:1369-
1380. doi:10.1177/147323001103900423. 
17.  G.Scuderi AT. The Knee: A Comprehensive Review.; 2010. 
18.  Elaine N. Marieb KH. Human Anatomy & Physiology.; 2012. 
19.  Total Knee Arthroplasty: American Academy of Orthopaedic Surgeons. 
http://orthoinfo.aaos.org/topic.cfm?topic=a00389. 
20.  Henningsen MH, Jaeger P, Hilsted KL, Dahl JB. Prevalence of saphenous nerve 
injury after adductor-canal-blockade in patients receiving total knee arthroplasty. 
Acta Anaesthesiol Scand. 2013;57(September 2011):112-117. doi:10.1111/j.1399-
6576.2012.02792.x. 
21.  C. Egeler AJ and SF. Motor-sparing knee block – description of a new technique. 
Anaesthesia. 2013;68:541-542. doi:10.1111/anae.12246. 
22.  Editiorial Board. Life with Arthritis in Canada: A Personal and Public Health 
Challaenge.; 2010. 
23.  Stafinski T, Menon D. THE BURDEN OF OSTEOARTHRITIS IN CANADA  : 
Working Paper 01-03. 2003;(June):1-20. http://www.ihe.ca/documents/2001-
03paper.pdf. 
24.  Kean WF, Kean R, Buchanan WW. Osteoarthritis: symptoms, signs and source of 
pain. Inflammopharmacology. 2004;12(1):3-31. 
doi:10.1163/156856004773121347. 
25.  Tarride JE, Haq M, O’Reilly DJ, et al. The excess burden of osteoarthritis in the 
province of Ontario, Canada. Arthritis Rheum. 2012;64(4):1153-1161. 
doi:10.1002/art.33467. 
78 
 
26.  The Arthritis Society. 2015. http://www.arthritis.ca/page.aspx?pid=941. 
27.  Macdonald K V, Sanmartin C, Langlois K, Marshall DA. Symptom Onset , 
Diagnosis and Management of Osteoarthritis.; 2014. 
28.  Lanting BA, Liberman JR, Callaghan JJ, Berend ME MS. Ensuring a Winner: The 
ABCs of Primary Total Knee Arthoplasty. 2015;64:369-379. 
29.  Chang CB, Yoo JH, Koh IJ, Kang YG, Seong SC, Kim TK. Key factors in 
determining surgical timing of total knee arthroplasty in osteoarthritic patients: 
Age, radiographic severity, and symptomatic severity. J Orthop Traumatol. 
2010;11:21-27. doi:10.1007/s10195-010-0086-y. 
30.  Ethgen O, Bruyère O, Richy F, Dardennes C, Reginster J-Y. Health-related quality 
of life in total hip and total knee arthroplasty. J Bone Jt Surg. 2004;86-
A(May):963-974. 
31.  Canadian Institute for Health Information. Hip and Knee Replacements in Canada: 
Canadian Joint Replacement Registry 2014 Annual Report. 2014;(June). 
32.  Krych APM. Review  : femoral nerve block may be the most effective option for 
pain relief following total knee replacement. BMJ. 2014;10(0):101918. 
doi:10.1055/s-0034-1371769. 
33.  Bauer MCR, Pogatzki-Zahn EM, Zahn PK. Regional analgesia techniques for total 
knee replacement. Curr Opin Anaesthesiol. 2014:1-6. 
doi:10.1097/ACO.0000000000000115. 
34.  Horlocker TT, Hebl JR, Kinney M a O, Cabanela ME. Opioid-free analgesia 
following total knee arthroplasty - A multimodal approach using continuous 
lumbar plexus (psoas compartment) block, acetaminophen, and ketorolac. Reg 
Anesth Pain Med. 2002;27(1):105-108. doi:10.1053/rapm.2002.27177. 
79 
 
35.  Chavis SW, Duncan LH. Pain management--continuum of care for surgical 
patients. AORN J. 2003;78:382-386, 389-399; quiz 400-401, 403-404. 
doi:10.1016/S0001-2092(06)60750-3. 
36.  Hawker G, Wright J, Coyte P, et al. Health-related quality of life after knee 
replacement. J Bone Joint Surg Am. 1998;80:163-173. 
37.  Antoni M, Jenny JY, Noll E. Postoperative pain control by intra-articular local 
anesthesia versus femoral nerve block following total knee arthroplasty: Impact on 
discharge. Orthop Traumatol Surg Res. 2014;100(3):313-316. 
doi:10.1016/j.otsr.2013.12.022. 
38.  Bagsby DT, Ireland PH, Meneghini RM. Liposomal Bupivacaine Versus 
Traditional Periarticular Injection for Pain Control After Total Knee Arthroplasty. 
J Arthroplasty. 2014;29(8):1687-1690. doi:10.1016/j.arth.2014.03.034. 
39.  Lamplot JD, Wagner ER, Manning DW. Multimodal pain management in total 
knee arthroplasty. a prospective randomized controlled trial. J Arthroplasty. 
2014;29(2):329-334. doi:10.1016/j.arth.2013.06.005. 
40.  Stein C, Lang LJ. Peripheral mechanisms of opioid analgesia. Curr Opin 
Pharmacol. 2009;9(Figure 1):3-8. doi:10.1016/j.coph.2008.12.009. 
41.  Affas F, Nygårds E-B, Stiller C-O, Wretenberg P, Olofsson C. Pain control after 
total knee arthroplasty: a randomized trial comparing local infiltration anesthesia 
and continuous femoral block. Acta Orthop. 2011;82(3):441-447. 
doi:10.3109/17453674.2011.581264. 
42.  Rawal N. Epidural technique for postoperative pain: gold standard no more? Reg 
Anesth Pain Med. 2012;37(3):310-317. doi:10.1097/AAP.0b013e31825735c6. 
43.  Tammachote N, Kanitnate S, Manuwong S, Yakumpor T, Panichkul P. Is pain 
after TKA better with periarticular injection or intrathecal morphine? Clin Orthop 
Relat Res. 2013;471:1992-1999. doi:10.1007/s11999-013-2826-9. 
80 
 
44.  Serpell MG, Millar F a, Thomson MF. Comparison of lumbar plexus block versus 
conventional opioid analgesia after total knee replacement. Anaesthesia. 
1991;46(July 1990):275-277. 
45.  Kuthiala G, Chaudhary G. Ropivacaine: A review of its pharmacology and clinical 
use. Indian J Anaesth. 2011;55(2):104-110. doi:10.4103/0019-5049.79875. 
46.  Knudsen K, Beckman Suurküla M, Blomberg S, Sjövall J, Edvardsson N. Central 
nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine 
and placebo in volunteers. Br J Anaesth. 1997;78:507-514. 
doi:10.1093/bja/78.5.507. 
47.  Banerjee P. The efficacy of multimodal high-volume wound infiltration in primary 
total knee replacement in facilitating immediate post-operative pain relief and 
attainment of early rehabilitation milestones. Eur J Orthop Surg Traumatol. 
2014;24:571-577. doi:10.1007/s00590-013-1231-0. 
48.  Busch C a, Shore BJ, Bhandari R, et al. Efficacy of periarticular multimodal drug 
injection in total knee arthroplasty. A randomized trial. J Bone Joint Surg Am. 
2006;88:959-963. doi:10.2106/JBJS.E.00344. 
49.  Andersen K V., Nikolajsen L, Haraldsted V, Odgaard a., Søballe K. Local 
infiltration analgesia for total knee arthroplasty: Should ketorolac be added? Br J 
Anaesth. 2013;111(March):242-248. doi:10.1093/bja/aet030. 
50.  Winnie a P, Ramamurthy S, Durrani Z. The inguinal paravascular technic of 
lumbar plexus anesthesia: the “3-in-1 block”. Anesth Analg. 1973;52:989-996. 
doi:10.1213/00000539-197311000-00036. 
51.  Faust AM, Fournier R, Gamulin Z. Perioperative Analgesia With Posterior 
Continuous Lumbar Plexus Block for Simultaneous Ipsilateral Total Hip and Knee 
Arthroplasty. Reg Anesth Pain Med. 2006;31:591. 
doi:10.1016/j.rapm.2006.08.007. 
81 
 
52.  Luber MJ, Greengrass R, Vail TP. Patient satisfaction and effectiveness of lumbar 
plexus and sciatic nerve block for total knee arthroplasty. J Arthroplasty. 
2001;16(1):17-21. doi:10.1054/arth.2001.16488. 
53.  Watson MW, Mitra D, McLintock TC, Grant S a. Continuous versus single-
injection lumbar plexus blocks: Comparison of the effects on morphine use and 
early recovery after total knee arthroplasty. Reg Anesth Pain Med. 2005;30(6):541-
547. doi:10.1016/j.rapm.2005.06.006. 
54.  Touray ST, De Leeuw M a., Zuurmond WW a, Perez RSGM. Psoas compartment 
block for lower extremity surgery: A meta-analysis. Br J Anaesth. 
2008;101(December 2007):750-760. doi:10.1093/bja/aen298. 
55.  Kaloul I, Guay J, Côté C, Fallaha M. The posterior lumbar plexus (psoas 
compartment) block and the three-in-one femoral nerve block provide similar 
postoperative analgesia after total knee replacement. Can J Anaesth. 
2004;51(October 2002):45-51. doi:10.1007/BF03018546. 
56.  Labat G. Regional Anesthesia Its Technical and Clinical Application.; 1924. 
57.  Paul, James E. Arya, Aman. Hurlburt, Lindsay. Cheng, Ji. Thabane L. Femoral 
Nerve Block Improves Analgesia Outcomes after Total Knee Arthroplasty. J Am 
Soceity Anesthesiol. 2010;113(5):1144-1162. 
58.  Sakai N, Inoue T, Kunugiza Y, Tomita T, Mashimo T. Continuous femoral versus 
epidural block for attainment of 120° knee flexion after total knee arthroplasty: A 
randomized controlled trial. J Arthroplasty. 2013;28(5):807-814. 
doi:10.1016/j.arth.2012.09.013. 
59.  Min Lee R, Lim Tey JB, Liang Chua NH. Postoperative Pain Control for Total 
Knee Arthroplasty: Continuous Femoral Nerve Block Versus Intravenous Patient 
Controlled Analgesia. Anesthesiol Pain Med. 2012;1(4):239-242. 
doi:10.5812/aapm.3404. 
82 
 
60.  Chan EY, Fransen M, Sathappan S, Chua NHL, Chan YH, Chua N. Comparing the 
Analgesia Effects of Single-injection and Continuous Femoral Nerve Blocks with 
Patient Controlled Analgesia after Total Knee Arthroplasty. J Arthroplasty. 
2013;28(4):608-613. doi:10.1016/j.arth.2012.06.039. 
61.  Ilfeld BM. The Association Between Lower Extremity Continous Peripheral Nerve 
Blocks and Patient Falls After Knee and Hip Arthroplasty. Changes. 
2012;29(6):997-1003. doi:10.1016/j.biotechadv.2011.08.021.Secreted. 
62.  Jenstrup MT, Jæger P, Lund J, et al. Effects of Adductor-Canal-Blockade on pain 
and ambulation after total knee arthroplasty: A randomized study. Acta 
Anaesthesiol Scand. 2012;56:357-364. doi:10.1111/j.1399-6576.2011.02621.x. 
63.  LaReau JM, Robbins CE, Talmo CT, Mehio AK, Puri L, Bono J V. Complications 
of Femoral Nerve Blockade in Total Knee Arthroplasty and Strategies to Reduce 
Patient Risk. J Arthroplasty. 2012;27(4):564-568. doi:10.1016/j.arth.2011.06.028. 
64.  Pelt CE, Anderson AW, Anderson MB, Dine C Van, Peters CL. Postoperative 
Falls After Total Knee Arthroplasty in Patients With a Femoral Nerve Catheter  : 
Can We Reduce the Incidence  ? J Arthroplasty. 2014;29(6):1154-1157. 
doi:10.1016/j.arth.2014.01.006. 
65.  Lund J, Jenstrup MT, Jæger P, Sørensen a. M, Dahl JB. Continuous adductor-
canal-blockade for adjuvant post-operative analgesia after major knee surgery: 
Preliminary results. Acta Anaesthesiol Scand. 2011;55(3):14-19. 
doi:10.1111/j.1399-6576.2010.02333.x. 
66.  Quemby D. Ultrasound Guided Adductor Canal Block ( Saphenous Nerve Block ). 
Atotw. 2014;(January):1-11. 
67.  DeLoach LJ, Higgins MS, Caplan a B, Stiff JL. The visual analog scale in the 
immediate postoperative period: intrasubject variability and correlation with a 
numeric scale. Anesth Analg. 1998;86(1):102-106. doi:10.1097/00000539-
199801000-00020. 
83 
 
68.  Kim TW, Park SJ, Lim SH, Seong SC, Lee S, Lee MC. Which analgesic mixture is 
appropriate for periarticular injection after total knee arthroplasty? Prospective, 
randomized, double-blind study. Knee Surgery, Sport Traumatol Arthrosc. 
2014;23:838-845. doi:10.1007/s00167-014-3366-x. 
69.  Xu CP, Li X, Wang ZZ, Song JQ, Yu B. Efficacy and safety of single-dose local 
infiltration of analgesia in total knee arthroplasty: A meta-analysis of randomized 
controlled trials. Knee. 2014;21(3):636-646. doi:10.1016/j.knee.2014.02.024. 
70.  Quinn M, Deakin a. H, McDonald D a., Cunningham IKT, Payne a. P, Picard F. 
An anatomic study of local infiltration analgesia in total knee arthroplasty. Knee. 
2013;20(5):319-323. doi:10.1016/j.knee.2013.06.008. 
71.  Kerr DR, Kohan L. Local infiltration analgesia: a technique for the control of acute 
postoperative pain following knee and hip surgery: a case study of 325 patients. 
Acta Orthop. 2008;79(2):174-183. doi:10.1080/17453670710014950. 
72.  Ramamoorthy K. Local Infiltratoin Analgesia Following Total Knee Arthroplasty. 
Indian J Anaesth. 2012;56(2):208-209. doi:10.4103/0019-5049.68372. 
73.  Niemeläinen M, Kalliovalkama J, Aho AJ, Moilanen T, Eskelinen A. Single 
periarticular local infiltration analgesia reduces opiate consumption until 48 hours 
after total knee arthroplasty. Acta Orthop. 2014;85(6):614-619. 
doi:10.3109/17453674.2014.961399. 
74.  Essving P, Axelsson K, Åberg E, Spännar H, Gupta A, Lundin A. Local 
infiltration analgesia versus intrathecal morphine for postoperative pain 
management after total knee arthroplasty: A randomized controlled trial. Anesth 
Analg. 2011;113(4):926-933. doi:10.1213/ANE.0b013e3182288deb. 
75.  Thorsell M, Holst P, Hyldahl HC, Weidenhielm L. Pain control after total knee 
arthroplasty: a prospective study comparing local infiltration anesthesia and 
epidural anesthesia. Orthopedics. 2010;33(2):75-80. doi:10.3928/01477447-
20100104-13. 
84 
 
76.  Fowler SJ, Christelis N. High volume local infiltration analgesia compared to 
peripheral nerve block for hip and knee arthroplasty - What is the evidence? 
Anaesth Intensive Care. 2013;41(4):458-462. 
77.  Tietje T, Davis a. B, Rivey MP. Comparison of 2 Methods of Local Anesthetic-
Based Injection as Part of a Multimodal Approach to Pain Management After 
Total Knee Arthroplasty. J Pharm Pract. 2014. doi:10.1177/0897190014544815. 
78.  Wang C, Cai X-Z, Yan S-G. Comparison of Periarticular Multimodal Drug 
Injection and Femoral Nerve Block for Postoperative Pain Management in Total 
Knee Arthroplasty: A Systematic Review and Meta-Analysis. J Arthroplasty. 
2015;(October 2014). doi:10.1016/j.arth.2015.02.005. 
79.  Moghtadaei M, Farahini H, Faiz SH-R, Mokarami F, Safari S. Pain Management 
for Total Knee Arthroplasty: Single-Injection Femoral Nerve Block versus Local 
Infiltration Analgesia. Iran Red Crescent Med J. 2014;16(1):e13247. 
doi:10.5812/ircmj.13247. 
80.  Marques EM, Jones HE, Elvers KT, Pyke M, Blom AW, Beswick AD. Local 
anaesthetic infiltration for peri-operative pain control in total hip and knee 
replacement: systematic review and meta-analyses of short- and long-term 
effectiveness. BMC Musculoskelet Disord. 2014;15(1):220. doi:10.1186/1471-
2474-15-220. 
81.  Perlas A, Kirkham KR, Billing R, et al. The impact of analgesic modality on early 
ambulation following total knee arthroplasty. Reg Anesth Pain Med. 
2013;38(4):334-339. doi:10.1097/AAP.0b013e318296b6a0. 
82.  Williamson A, Hoggart B. Pain: A review of three commonly used pain rating 
scales. J Clin Nurs. 2005;14(7):798-804. doi:10.1111/j.1365-2702.2005.01121.x. 
83.  Stark T, Walker B, Phillips JK, Fejer R, Beck R. Hand-held dynamometry 
correlation with the gold standard isokinetic dynamometry: A systematic review. 
PM R. 2011;3(5):472-479. doi:10.1016/j.pmrj.2010.10.025. 
85 
 
84.  McConnell S, Kolopack P, Davis a M. The Western Ontario and McMaster 
Universities Osteoarthritis Index (WOMAC): a review of its utility and 
measurement properties. Arthritis Rheum. 2001;45(5):453-461. doi:10.1002/1529-
0131(200110)45:5<453::AID-ART365>3.0.CO;2-W. 
85.  Liebs TR, Gluth J, Rüther W, Haasters J, Russlies M, Hassenpflug J. Using the 
patient ’ s perspective to develop function short forms specific to total hip and 
knee replacement based on WOMAC function items. J Bone Jt Surg. 
2013;95(2):239-243. doi:10.1302/0301-620X.95B2.28383. 
86.  Marsh JD, Bryant DM, MacDonald SJ, Naudie DDR. Patients Respond Similarly 
to Paper and Electronic Versions of the WOMAC and SF-12 Following Total Joint 
Arthroplasty. J Arthroplasty. 2014;29(4):670-673. doi:10.1016/j.arth.2013.07.008. 
87.  Ware JE, Highway GW. SF-12 ® Health Survey (Version 1.0). Management.:1-8. 
88.  Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: 
construction of scales and preliminary tests of reliability and validity. Med Care. 
1996;34(3):220-233. doi:10.2307/3766749. 
89.  Yeung TSM, Wessel J, Stratford PW, MacDermid JC. The timed up and go test for 
use on an inpatient orthopaedic rehabilitation ward. J Orthop Sports Phys Ther. 
2008;38(7):410-417. doi:10.2519/jospt.2008.2657. 
90.  Halket A, Stratford PW, Kennedy DM, Woodhouse LJ, Spadoni G. Measurement 
properties of performance-specific pain ratings of patients awaiting total joint 
arthroplasty as a consequence of osteoarthritis. Physiother Can. 2008;60(3):255-
263. doi:10.3138/physio.60.3.255. 
91.  D. Podsiadlo SR. The Timed “Up & Go”: A Test of Basic Functional Mobility for 
Frail Elderly Persons. JAGS. 1991;39:142-148. 
92.  Jæger P, Zaric D, Fomsgaard JS, et al. Adductor Canal Block Versus Femoral 
Nerve Block for Analgesia After Total Knee Arthroplasty. Reg Anesth Pain Med. 
2013;38(6):526-532. doi:10.1097/AAP.0000000000000015. 
86 
 
93.  Szucs S, Iohom G, O’Donnell B, et al. Analgesic efficacy of continuous femoral 
nerve block commenced prior to operative fixation of fractured neck of femur. 
Perioper Med (London, England). 2012;1:4. doi:10.1186/2047-0525-1-4. 
94.  The 2011 Knee Society Knee Scoring System ©. 2012;(December):1-9. 
95.  Ryd L, Kärrholm J, Ahlvin P. Knee scoring systems in gonarthrosis. Evaluation of 
interobserver variability and the envelope of bias. Score Assessment Group. Acta 
Orthop Scand. 1997;68(1):41-45. doi:10.3109/17453679709003973. 
96.  Mudumbai SC, Kim TE, Howard SK, et al. Continuous adductor canal blocks are 
superior to continuous femoral nerve blocks in promoting early ambulation after 
TKA. Clin Orthop Relat Res. 2014;472:1377-1383. doi:10.1007/s11999-013-3197-
y.  
 
 
87 
 
Appendices  
 
Appendix A: Ethics Approval 
 
88 
 
 
89 
 
 
Appendix B: Letter of Information and Consent 
 
90 
 
 
91 
 
 
92 
 
 
93 
 
 
94 
 
 
95 
 
 
96 
 
Appendix C: Image Permissions 
 
 
97 
 
 
  
  
 
 
 
98 
 
Curriculum  Vitae  
  
Olawale Sogbein 
EDUCATION 
Master of Science   Kinesiology, Sports Medicine 
     University of Western Ontario, London, ON 
     September 2013 – August 2015 
 
Master of Environmental Studies Nipissing University, North Bay, ON 
     September 2012-August 2013 
Honours Bachelor of Science Health Sciences 
Dean’s List    University of Ottawa, Ottawa, On 
     Class of 2012	  	  
RESEARCH EXPERIENCE 
University of Western Ontario University Hospital, London Health Sciences Centre  
London, ON Under the supervision of Dr. Dianne Bryant  
Thesis Project and co-advisory of Dr. James Howard. 
2013 – Present Conduct a randomized controlled trial investigating  
 a motor sparing block in postoperative
 analgesia. Responsible for patient recruitment,
 follow-up, data collection and entry, statistical 
analysis. 
 
Nipissing University  Under the supervision of Dr. Stephen Kariuki. 
North Bay, ON Assisted with the conducting of experiments and  
Research Assistant data collection.  
2012 – 2013 
 
CONFERENCES 
Toronto, ON Bodies of Knowledge Graduate Student Conference 
Presenter Presented thesis work regarding motor sparing   
May 2014 blocks for postoperative analgesia following total 
 knee arthroplasty. 
London, ON Three-Minute Thesis Competition 
99 
 
Presenter Presented a proposal for my thesis work regarding 
April 2014 motor sparing blocks for postoperative analgesia 
 following total knee arthroplasty.  
 
TEACHING EXPERIENCE 
University of Western Ontario Introduction to Athletic Injuries 
London, ON Kinesiology 2236B 
Teaching Assistant 
Winter 2014 and 2015 
University of Western Ontario Medical Issues in Exercise and Sport 
London, ON Kinesiology 4437A 
Teaching Assistant 
Fall 2013 and 2014 
HONOURS & AWARDS 
2015 Kinesiology Graduate Travel Award 
2013-2015 Western Graduate Research Scholarship 
2014 Faculty of Health Science Travel Award 
2009-2012 University of Ottawa Dean’s Honour List 
 
 
  
  
 	  	  
